Wayne State University
Wayne State University Dissertations

1-1-2011

Compensatory renal hypertrophy, mitochondria
and redox status
Bavneet Benipal
Wayne State University,

Follow this and additional works at: http://digitalcommons.wayne.edu/oa_dissertations
Part of the Pharmacology Commons, and the Toxicology Commons
Recommended Citation
Benipal, Bavneet, "Compensatory renal hypertrophy, mitochondria and redox status" (2011). Wayne State University Dissertations.
Paper 343.

This Open Access Dissertation is brought to you for free and open access by DigitalCommons@WayneState. It has been accepted for inclusion in
Wayne State University Dissertations by an authorized administrator of DigitalCommons@WayneState.

COMPENSATORY RENAL HYPERTROPHY, MITOCHONDRIA AND REDOX
STATUS
by
BAVNEET BENIPAL
DISSERTATION
Submitted to the Graduate School
of Wayne State University,
Detroit, Michigan
in partial fulfillment of the requirements
for the degree of
DOCTOR OF PHILOSOPHY
2011
MAJOR: PHARMACOLOGY
Approved by:

----------------------------------------------------------Advisor
Date

-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

DEDICATION

I dedicate this work to my family and friends that helped me in reaching my academic goals
and become the person I am today. I would like to give the most recognition to the following
people:
My parents, Sukhpal and Lakhbir Benipal who have been my role model for hard work
throughout my whole life. I deeply appreciate their love, support, encouragement and faith in
me. My grandfather, Raghbir Benipal who always emphasized the importance of education
and provided me unconditional encouragement and support.

ii

ACKNOWLEDGMENTS

My deepest gratitude is to my mentor, Dr. Lawrence H. Lash. I have been fortunate to have an
advisor who provided me an independent environment to develop my project and at the same
time the guidance and support to overcome many challenges and finish this dissertation.
I would also like to thank my committee members, Dr. Thomas Kocarek, Dr. Todd Leff, Dr.
Roy McCauley and Dr. Julie Boerner for their valuable advice and constructive criticism at
different stages of my research. I would also like to acknowledge David Putt for his
invaluable assistance and long discussions that helped me improve my knowledge and sort out
the technical details of my work. I truly appreciate his encouragement, supervision, patience
and most importantly, his friendship over the last few years.
Finally and most importantly, I would like to express my gratitude to my family, who has
been a constant source of love, support and strength all these years.

iii

TABLE OF CONTENTS

Dedication ………………..…..………………………………………………………….

ii

Acknowledgments ……….….…………………………………………………………..

iii

List of Tables ……………………………………………………………………………

x

List of Figures ………….……………………………………………………………….

xi

List of Abbreviations …………..……………………………………………………….

xiii

CHAPTER I. INTRODUCTION ……………………………………………………..

1

Reduction in functional renal mass

……………………………………………….

1

Compensatory renal hypertrophy: Cellular and molecular events underlying
compensatory renal hypertrophy ……………………………………………………….

5

Compensatory renal hypertrophy, mitochondria, nephrotoxicity and clinical
complications …………………………………………………………………………….

7

Function and importance of thiol redox status in renal function in proximal tubules ..

10

Pathways of glutathione transport in renal proximal tubule ………………………….

18

iv

Mitochondrial GSH status, transporters, and mechanisms of renal mitochondrial GSH
transport …………………………………………………………………………………

23

Significance of mitochondrial GSH transport in protection from oxidative stress …

27

Goals of present study …………………………………………………........................

29

CHAPTER II. MATERIALS AND METHODS ………………………………….....

33

………………………………..………………………….………….........

33

II-1 RENAL FUNCTION AND MITOCHONDRIAL STATUS ………………………

34

Chemicals

……….……………………………………………………………………

34

………………………………………………………………………..........

34

Animals

Methods

In vivo assessment of renal physiological parameters …………………………….….

34

Determination of protein expression of renal plasma membrane organic anion
transporters by Western blot analysis ………………………………………………….

35

Determination of protein expression of renal mitochondrial GSH transporters and redox
status proteins by Western blot analysis ……………………………………….………

36

Analysis of gene expression by real-time PCR ……………………………..………….

37

Determination of mitochondrial GSH status …………………………………………..

37

Enzyme assays and protein expression …………...……………………………………

37

v

GSSG reductase assay ………………….…….…………………………………………

38

GSH peroxidase assay ……………..…………………….……………………………...

38

GSH S-transferase assay ………………….…………………………………………….

38

Glutamate dehydrogenase assay ….............…………………………………………….

38

Malic dehydrogenase assay …..………..………………………………………….........

39

Succinate: cytochrome c oxidoreductase assay …………………………………...........

39

Protein determination …………………………………………………………………...

39

Mitochondrial oxygen consumption …………………………………………………….

40

Mitochondrial proteomics ………………………………………………………………

40

Assessment of basal and toxicant-induced mitochondrial oxidative stress …………

41

Lipid peroxidation by malondialdehyde assay ………………………………………..

41

Lipid peroxidation by cis-parinaric acid fluorescence assay …………………………

41

Mitochondrial aconitase activity ………………………………………………………..

42

Analysis of oxidative stress markers by Western blot analysis ………………………

42

Effect of toxicant (tBH) on mitochondrial protein expression during compensatory renal
hypertrophy ………………………………………………………………………………

Data analysis …………………………………………………………………………….

vi

43
43

II-2 STUDIES IN PROXIMAL TUBULAR CELL PRIMARY CULTURES …………

44

Chemicals ………………………………………………………………………………..

44

Culture of rat proximal tubular cells ……………………………………………………

44

MitoTrackerTM orange staining ..………………………………………………………..

46

JC-1

(5,5‟,6,6‟-tetrachloro-1,1‟,3,3‟-tetraethylbenzyimidazolyl-carbocyanine

iodide)

staining .…………………………………………………………………………………..

47

DNA fluorescence assay ………………………………………………………………..

47

Mitochondrial protein assay ……….……………………………………………...........

48

Transfection ………………………………………………………………………….….

48

Gene expression by real-time PCR …………………………………………………….

49

Assay for assessment of cytotoxicity …………………………………………………..

49

Data analysis ……………………………………………………………………...……

50

CHAPTER III. RENAL FUNCTION ……………………………………………….

51

Renal physiological parameters in vivo ………………………………………………..

51

Results ………………………………………………………………………………….

51

Discussion ………………………………………………………………………………

54

Protein and gene expression analysis of renal plasma membrane organic anion

vii

transporters …………………………………………………………………………......

56

Results …………………………………………………………………………………..

56

Discussion ………………………………………………………………………………

61

CHAPTER IV. MITOCHONDRIAL STATUS …………………………………….

63

Mitochondrial redox status ……………………………………………………………..

63

Results …………………………………………………………………………..………

63

Discussion ………………………………………………………………………………

70

Impact of compensatory hypertrophy on functional characteristics of renal mitochondria

72

Enzyme results ………………………………………………………………………….

72

Respiration results ………………………………………………………………………

75

Proteomics results ………………………………………………………………………

77

Discussion ………………………………………………………………………………

81

Assessment of basal and toxicant-induced oxidative stress in renal mitochondria ..

83

Results …………………………………………………………………………………..

83

Discussion ………………………………………………………………………………

93

Effect of compensatory renal hypertrophy on mitochondrial size, number and membrane
potential ………………………………………………………………………………….

viii

96

Results …………………………………………………………………………………..

96

Discussion ………………………………………………………………………………

104

CHAPTER V.

MODULATION OF MITOCHONDRIAL REDOX STATUS IN

PROXIMAL TUBULAR CELLS TO REDUCE THE RISK OF SUSCEPTIBILTY
TO NEPHROTOXICANTS ……………………………………………………………
105
Influence of overexpression of the DIC on susceptibility to chemically induced toxicity
by mitochondrial toxicants …………………………….………………………………

Results …………………………….…………………………………………………….

105
105

Influence of overexpression of the OGC on susceptibility to chemically induced toxicity
by mitochondrial toxicants …………………………………………………………….

110

Results …………………………….…………………………………………………….

110

Discussion …………………………………………………….………………………..

115

CHAPTER VI. SUMMARY AND CONCLUSIONS .………………………………

119

CHAPTER VII. OVERALL SIGNIFICANCE AND FUTURE DIRECTIONS …

125

References ………………….…………………………………………………………...

129

Abstract ……….………………………………………………………………………...

151

Autobiographical Statement …………………………………………………………....

153

ix

LIST OF TABLES

Table 1-1. Mitochondrial anion transporters …………….........................................

26

Table 3-1. Physiological parameters of renal function in vivo …………....................

52

Table 3-2. Real-time quantitative PCR analysis of Oat1 and Oat3 mRNA expression in
renal cortex of control and NPX rats ….…………………………………..
Table 4-1. GSH and GSSG concentrations in renal mitochondria from control and NPX
rats …………………………………………………………………………..
Table 4-2. Real-time quantitative PCR analysis of DIC and OGC mRNA expression in
renal cortex of control and NPX rats .………….………………………….
Table 4-3. Effects of compensatory renal hypertrophy on GSH-dependent and
mitochondrial enzymes……………………………………………………

60

64

67

73

Table 4-4. Effects of compensatory renal hypertrophy on mitochondrial respiration ..

76

Table 4-5. Mitochondrial proteomics ……………….………………………………..

78

Table 4-6. Effect of toxicant (tBH) on mitochondrial protein expression during
compensatory renal hypertrophy .…….…………………………………
Table 5-1. Analysis of DIC gene overexpression by RT-PCR in renal proximal tubular
cells from NPX rats .…………………………….………………………….
Table 5-2. Analysis of OGC gene overexpression by RT-PCR in renal proximal tubule
cells from NPX rats ………………………………………………………....

x

88

106

111

LIST OF FIGURES

Figure 1-1. Kidney structure …………………….. ………………………………........

3

Figure 1-2. From blood filtrate to urine: A closer look .............................................

4

Figure 1-3. Glutathione (GSH) structure ……………………………………………...

12

Figure 1-4. Functions of glutathione (GSH) .……………………………………….....

13

Figure 1-5. Glutathione synthesis .…………………………………………….……….

16

Figure 1-6. Interorgan transport and metabolism of GSH …………………………....

17

Figure 1-7. Pathways for GSH transport and metabolism in renal proximal tubular cells

20

Figure 1-8. Schematic summary of renal plasma membrane transporters .................

21

Figure 1-9. Mitochondrial GSH content and transport .………………………………

25

Figure 3-1. Effect of compensatory renal growth on protein expression of renal plasma
membrane organic anion transporters and the (Na+ + K+)-stimulated
58
ATPase …………………………………………………………………….
Figure 4-1. Effect of compensatory renal growth on protein expression of renal
mitochondrial GSH transporters .……...................................................
Figure 4-2. Effect of compensatory renal growth on protein expression of renal
mitochondrial Sod2 and Trx2 …………….............................................
Figure 4-3. Assessment of effects of compensatory renal growth on basal and toxicant
induced oxidative stress in renal mitochondria …………………….…....
Figure 4-4. MitoTrackerTM staining ……………………………………………………

xi

65

68

86
98

Figure 4-5. Mitochondrial DNA ……………………………….………………………

100

Figure 4-6. Mitochondrial protein ………………………..……………………………

101

Figure 4-7. Measurement of mitochondrial membrane potential in PT cells from control
and NPX rats ………………………………………………………………
Figure 5-1. Effect of overexpression of the DIC on sensitivity to chemical-induced
toxicity ……………………….……………………………………………
Figure 5-2. Effect of overexpression of the OGC on sensitivity to chemical-induced
toxicity ……………………………………………………………………

102

107

112

Figure 5-3. Mitochondrial toxicants ……………………………………………….....

118

Figure 6-1. Summary scheme ………………………………………………...............

124

xii

LIST OF ABBREVIATIONS

AA

Antimycin A

Acivicin

L-(αS,5S)-α-amino-3-chloro-4,5-dihydro-5isoxazoleacetic acid;

BBM

Brush-border plasma membrane

BLM

Basolateral plasma membrane

CM

canalicular membrane;

Cys

Cysteine

DIC

Dicarboxylate carrier

GAPDH

glyceraldehyde 3-phosphate dehydrogenase

GCS

L- -glutamyl-L-cysteine synthetase

GGT

-glutamyltransferase

GLRX

Glutaredoxin

GPX

glutathione peroxidase

GRD

glutathione disulfide Reductase

GS

GSH synthetase

xiii

GS-

Thiolate anion of glutathione

GSH

Glutathione

GS–R

GSH conjugate

GSSG

Glutathione disulfide

GST

Glutathione S-transferase

HNE

4-Hydroxy-2-nonenal

LDH

Lactate dehydrogenase

MDA

Malondialdehyde

MDH

Malic dehydrogenase

Mrp

Multidrug resistance protein

MVK

Methyl vinyl ketone

NaC3

Sodium-dicarboxylate 3 carrier

NAG

N-Acetyl- -D-glucosaminidase

NHE

Sodium-hydrogen exchanger

NPX

Uninephrectomized

NT

3-Nitrotyrosine

OA–

Organic anion

xiv

Oat1/3

Organic anion transporters 1 and 3

Oat-k1/k2

Kidney specific organic anion transporter

Oatp1

Organic anion transporting polypeptide 1

OC+

Organic cation

Oct

Organic cation transporter

OG2-

2-Oxoglutarate

OGC

2-Oxoglutarate carrier

OPT

o-Phthalaldehyde

Pi2-

Inorganic phosphate

PRX

Peroxiredoxin

PT

Proximal tubular

RCR

Respiratory control ratio

ROH

Lipid alcohol

ROOH

Lipid peroxide

ROS

Reactive oxygen species

SDH

Succinate: cytochrome c oxidoreductase

SM

Sinusoidal membrane

xv

Sod2

Superoxide dismutase 2

tBH

tert-Butyl hydroperoxide

Trx2

Thioredoxin 2

VDAC

Voltage-dependent anion channel (porin)

xvi

1
CHAPTER I. INTRODUCTION

Reduction in functional renal mass

Renal function is critical to life as the kidneys are responsible for filtering wastes, toxins and
fluids from the blood stream. The ability of the organ to function is a result of the collective
effort of a number of different types of kidney cells. As shown in Figures 1-1 and 1-2, the outer
section of the kidney is called the renal cortex and the inner section is called the medulla. The
kidneys are covered by a layer called the capsule. The nephron, the primary structural unit of the
kidneys, is comprised of specialized epithelial cells, including those of the glomerulus, proximal
tubule, the loop of Henle, distal tubules, and collecting duct, each with its own distinctive
morphology, physiology and biochemistry. Kidney cells display a higher susceptibility to several
toxicants due to physiological and biochemical reasons (Lash and Cummings, 2010).
Physiological factors include the fact that the kidneys receive 25% of the cardiac output, which
ensures that high levels of toxicants are delivered to renal cells. The kidneys also have a
tremendous ability to concentrate solutes, which results in high concentrations of toxicants in the
medullary lumen and interstitium. Biochemical factors include the presence of several
biotransformation enzymes that catalyze the formation of toxic metabolites and reactive
intermediates such as cytochrome P450 monooxygenases, glutathione S-transferases and flavincontaining monooxygenases. In addition, the high metabolic rate and workload of renal cells also
increases their sensitivity to toxicants.
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It is well known that reductions in functional renal mass occur in humans during aging and
severe kidney damage from diseases, injuries, infections and congenital conditions and after
nephrectomy. Nephrectomy, or surgical removal of a kidney or a section of a kidney, is
performed for treatment of unilateral, secondary renal cancer, infections and for kidney
transplantation. The incidence of reductions in renal mass is increasing in the U.S. and represents
a significant challenge to public healthcare. The number of patients treated with dialysis or
kidney transplantation was projected to increase from 340,000 in 1999 to 651,000 in 2010
(Holcomb, 2005). Reduction of renal mass due to nephrectomy results in increases in the size
(hypertrophy) and function of the remnant kidney cells, most prominently in the proximal tubular
(PT) region (Meyer et al., 1996), and this multistep adaptive process is called compensatory
renal hypertrophy.

Studies have shown that surgical removal of one kidney in experimental animals and patients
was performed in the nineteenth century and led to the observation that the remaining kidney
subsequently undergoes compensatory renal growth (Nowinski, 1969). In adult animals, 80% of
compensatory renal growth following uninephrectomy is reportedly due to hypertrophy, an
increase in cell size predominantly of proximal tubules, whereas 15-30% of growth can be
ascribed to hyperplasia, an increase in cell number (Johnson and Vera, 1966; Johnson, 1969).

3

Figure 1-1. Kidney Structure.
From Campbell and Reece (2005).

4

Figure 1-2. From blood filtrate to urine: A closer look.
From Campbell and Reece (2005).

5

Compensatory renal hypertrophy: Cellular and molecular events underlying compensatory
renal hypertrophy
Although the phenomenon of compensatory renal hypertrophy is well known and despite
extensive research over the past century, the mechanism of this process still remains unclear.
After the removal of one kidney, the remaining kidney exhibits a hyperfiltration state and
changes in glomerular hemodynamics that activate a series of growth events leading to
compensatory growth of the remaining kidney (Wesson, 1989; Fine and Norman, 1992). This
compensatory hypertrophy response is mediated by vasoactive molecules, cytokines, growth
factors and increases in glomerular capillary pressure and flow (Holcomb, 2005; Meyer et al.,
1996; Fine, 1986; Shirley and Walter, 1991).

The cellular characteristics of hypertrophy include increases in cellular volume, area and surface
density of the basolateral (BLM) and brush-border plasma membranes (BBM), increases in
cellular synthesis and content of glutathione (L-γ-glutamyl-L-cysteinyl-glycine, GSH) (Zalups
and Lash, 1990), and mitochondrial proliferation within renal PT cells (Johnson and Amendola,
1969). Physiological changes consist of increased glomerular filtration rate (GFR), renal blood
flow (RBF) and water and electrolyte transport (Shirley and Walter, 1991; Wolf and Neilson,
1991; Zalups and Henderson, 1992). Biochemical changes include increases in renal protein
content (Coe and Korty, 1967; Halliburton and Thomson, 1967), rates of renal protein synthesis
(Johnson and Vera Roman, 1966) and RNA synthesis (Johnson and Vera Roman, 1966;
Ouellette, 1983) and increased mitochondrial metabolism in proximal and distal tubules (Harris
et al., 1988; Nath et al., 1990; Shapiro et al., 1994).
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Additionally, activities of most renal enzymes increase in the hypertrophied kidney. For
example, increased activity of enzymes that are involved in excretion of solutes, such as the
(Na++K+)-stimulated ATPase (Mujais and Kurtzman, 1986; Scherzer et al., 1985) and enzymes
that contribute to cell growth, such as ornithine decarboxylase (Brandt et al., 1972; Humphreys
et al., 1988), guanylate cyclase, protein kinase C, enzymes of the pentose phosphate pathway
(Schlondorff and Weber, 1976; Caramelo et al., 1988; Steer et al., 1982), choline kinase and
choline phosphotransferase (Toback et al., 1974; Hise et al., 1984), are observed.

The sequential production of different growth factors is also required to achieve coordinated
growth of kidney cells after growth has been triggered by some unidentified kidney-specific
signal. There is also strong evidence that a large number of factors promote kidney growth in
cultured PT cells, including insulin, insulin-like growth factor (IGF-1), epidermal growth factor
(EGF), hepatocyte growth factor (HGF), platelet-derived growth factor, prostaglandin E2, and
hormones including hydrocortisone, thyroxine, arginine vasopressin and angiotensin (Fine, 1986;
Caramelo et al., 1988; Igawa et al., 1991). Moreover, recent studies suggest that transforming
growth factor- (TGF- ) is one of the most important factors causing tubular cell hypertrophy
(Franch et al., 1995; Fujita et al., 2004; Wolf et al., 1993; Sinuani et al., 2006). TGF- induces
hypertrophy of tubular cells through a cell cycle-dependent mechanism that involves entry of
cells into the G1 phase, initiating G1-related events, and arresting cell cycle progression prior to
the G1/S restriction point (Franch et al., 1995, 1997; Nagahara et al., 1999).

The toxicological implications of compensatory renal growth are higher susceptibility to
nephrotoxicants such as inorganic mercury, analgesics and cadmium metallothionein (Henry et
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al., 1983; Houser and Berndt, 1986; Lash and Zalups, 1992; Lash et al., 1999, 2006; Molland,
1976; Zalups, 1997; Zalups and Diamond, 1987; Zalups et al., 1992). Furthermore, previous
studies from our lab showed that cellular GSH content was significantly higher in renal
homogenates (whole kidney, cortex and outer stripe of the outer medulla) from
uninephrectomized (NPX) rats, suggesting that increased GSH content is an adaptive response to
enhanced oxidative stress (Zalups and Lash, 1990).

It has been further shown that there are many factors that influence the compensatory renal
growth response. For example, feeding a protein-rich diet increased kidney weight in NPX rats
(Hostetter et al., 1986), administration of androgens increased kidney weight in mice and rats
(Schlondorff et al., 1977; Blantz et al., 1988), and a greater growth response after
uninephrectomy was observed in young rats as compared to older rats (Barrows et al., 1962).
Conversely, starvation, protein depletion and endocrine abnormalities retard growth (Hayslet,
1979).

Compensatory renal hypertrophy, mitochondria, nephrotoxicity and clinical complications
The mitochondria are the primary organelle for production of ATP. Reducing equivalents from
malate and glycerol phosphate are transported from the cytoplasm into mitochondria by the
NADH shuttle system. Pyruvate, which is a product of glycolysis, enters mitochondria and is
metabolized by the citric acid cycle to produce NADH and FADH2. NADH and FADH2 further
go through the electron-transport chain located on the inner mitochondrial membrane to
synthesize ATP. The electron-transport chain consists of four enzyme complexes, denoted as
complexes I, II, III and IV. Complex I is the NADH:ubiquinone oxidoreductase. Complex II is
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the succinate:ubiquinone oxidoreductase. Complex III is the ubiquinol:cytochrome c
oxidoreductase, which is a ubisemiquinone radical-generating Q cycle and can be a site at which
1% to 2% of total oxygen consumption leaks to generate superoxide anion (O 2.-). Complex IV is
the cytochrome c oxidase.

Under normal conditions, mitochondrial reactive oxygen species (ROS) produced in the course
of metabolism are contained by the natural antioxidant system that protects cells from ROSmediated modifications. The main mitochondrial antioxidants are GSH, manganese superoxide
dismutase and thioredoxin systems. The antioxidant capacity of mitochondria is limited
compared to the cytoplasm and mitochondria depend on GSH transporters for their GSH supply.
The various antioxidants play a crucial role in protection from oxidative stress, which can be
caused by an increase in ROS or an impaired antioxidant defense system. Under various
abnormal conditions, the rate of ROS production may exceed the natural antioxidant capacity,
leading to oxidative stress. The primary ROS produced in the course of mitochondrial oxygen
metabolism is superoxide anion, which is a highly reactive and cytotoxic ROS.

Mitochondria are not only the main organelle that produces superoxide anion but are also the
main targets of ROS, leading to mitochondrial dysfunction. It has been shown that compensatory
renal hypertrophy results in increased energy demands on PT cells. To accommodate these
energy demands, there are increased rates of mitochondrial electron transport, which produces a
hypermetabolic state (Harris et al., 1988; Shapiro et al., 1994) that can lead to mitochondrial
dysfunction. In addition, our previous studies also showed in isolated mitochondria from
hypertrophied PT cells that although intramitochondrial GSH contents and activity are increased,
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these mitochondria exhibit an enhanced basal oxidative stress and greater sensitivity to
mitochondrial toxicants (Lash et al., 2001a). There is increasing evidence that in experimental
animals, compensatory renal hypertrophy increases risk for later toxicological complications due
to increased renal oxidative stress. For example, uninephrectomy and compensatory renal
hypertrophy result in markedly altered susceptibility to injury from a broad variety of
nephrotoxicants, including heavy metals, analgesics, and antibiotics (Zalups et al., 1992; Lash
and Zalups, 1992; Lash et al., 1999, 2006; Molland, 1976; Zalups, 1997; Zalups and Diamond,
1987).

There is also strong evidence in experimental animals that significant reduction in renal mass
leads to proteinuria, systemic and glomerular hypertension, glomerular hyperfiltration and
progressive renal damage (Hostetter et al., 2001; Remuzzi et al., 2006; Santos et al., 2006).
Studies also suggest this glomerular hypertension and glomerular hyperfiltration lead to
pathogenesis of proteinuria and progressive glomerulosclerosis (Hostetter et al., 2001). Ever
since the recognition of hyperfiltration injury in animals undergoing renal ablation, there has
been concern over the extended outcome after kidney donation. There is also strong clinical
evidence that suggests short and long-term medical risks of human renal donor nephrectomy for
transplantation purposes. The human clinical studies that investigated the quality of life of renal
donors found early and late health complications such as hypertension, microalbumiuria,
hematuria and proteinuria (Azar et al., 2007; Berber et al., 2008).
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Function and importance of thiol redox status in renal function in proximal tubules
Due to high rates of aerobic metabolism in the proximal tubules and high exposure to a broad
and diverse range of chemicals and drugs, the kidneys are highly dependent on adequate supply
of the thiol-disulfide redox protectant GSH to maintain proper function. Besides the GSH
system, there are other renal protective systems, including thioredoxin and low-molecular-weight
thiols such as N-acetyl-L-cysteine (NAC) (Lash, 2010). Several signaling pathways also function
in nephroprotection, such as the epidermal growth factor (EGF), mitogen activated protein kinase
(MAPK), protein kinase B (PKB/Akt), protein kinase C (PKC), heat shock proteins (HSPs), and
nuclear factor kappa-B (NF-ĸB) pathways; these act through modulation of redox status or by
altering cellular pH (Lash, 2010). Small amino acids, such as glycine, are also nephroprotective.

GSH is the most abundant non-protein thiol (SH) in mammalian cells. As shown in Figure 1-3,
GSH is a tripeptide composed of the amino acids L-glutamate, L-cysteine and glycine.
Glutathione can exist in two major forms: the antioxidant „reduced glutathione‟ tripeptide is
called glutathione and abbreviated GSH; the oxidized form is a sulfur-sulfur linked compound
known as glutathione disulfide or GSSG (Kidd, 1997). The GSH/GSSG ratio may be a sensitive
indicator of oxidative stress. The high electron-donating capacity of GSH due to its sulfhydryl (SH) group combined with its high intracellular concentration endow GSH with great reducing
power, which is used to regulate a complex thiol-exchange system (Franco, 2007). Glutathione is
present inside cells mainly in its reduced GSH form. Intracellular GSH status appears to be a
sensitive indicator of the overall health of the cell and of its ability to resist toxic challenges.

11

As shown in Figure 1-4, the primary, critical processes involving GSH are peroxide reduction,
electrophile conjugation, glutathionylation and action as a coenzyme in detoxification,
metabolism and hormone biosynthesis. GSH is considered the most important antioxidant in the
human body. GSH recycles other antioxidants, such as vitamins A, C and E, keeping them in an
active state longer and helping to prevent oxidative stress and inflammation. GSH is often called
„the master antioxidant.‟ GSH acts as a main detoxifier by binding to toxins such as heavy
metals, solvents and pesticides, allowing them to be excreted in urine or bile. GSH strengthens
the immune system by boosting production of T cells that fight viral and bacterial infections.
Elevated GSH levels help the body to produce more white blood cells. White blood cells are the
most important cells for maintaining sterility of body fluids by serving as garbage collectors for
the body. In other words, healthy growth and activity of white blood cells depend on availability
of GSH. It is widely accepted that GSH also acts as a mediator of many other physiological
reactions, including cellular signaling, metabolism of xenobiotics, thiol-disulfide exchange
reactions, and as an important reservoir of cysteine (Franco, 2007).

12

Figure 1-3. Glutathione (GSH) structure.
The L-glutamyl and L-cysteinyl residues are linked through the -carboxyl group of L-glutamate,
making the isopeptide bond resistant to most proteases. The tripeptide thiol glutathione (GSH)
has facile electron-donating capacity, linked to its sulfhydryl (–SH) group.
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Figure 1-4. Functions of glutathione (GSH).
The basic types of functions for GSH in cytoprotection are mentioned.
Abbreviations: E, electrophile; GLRX, glutaredoxin; GPX, GSH peroxidase; GRD, glutathione
disulfide reductase; GS–R, GSH conjugate; GSSG, glutathione disulfide; PRX, peroxiredoxin;
ROH, lipid alcohol; ROOH, lipid peroxide.
From Lash (2010).
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As shown in Figure 1-5, GSH is synthesized in the cytoplasm by two ATP-dependent reactions,
the glutamate-cysteine ligase (GCL) [also called γ-glutamyl cysteine synthetase (γ-GCS)] and
GSH synthetase (GS). In the first reaction, L-cysteine and L-glutamate are combined by glutamyl cysteinyl synthetase. In the second reaction, GSH synthetase combines -glutamylcysteine with glycine to generate GSH. Reduced glutathione (GSH) is oxidized to glutathione
disulfide (GSSG) in a reaction catalyzed by glutathione peroxidase and GSSG is reduced to
regenerate GSH by glutathione reductase, which uses NADPH as a hydrogen donor. GSH
degradation is mediated by either a hydrolysis or transpeptidation reaction catalyzed by glutamyltransferase (GGT), followed by hydrolysis catalyzed by dipeptidase (DP) activity. The
major difference between synthesis and degradation is that whereas degradation occurs
extracellularly, as both GGT and DP face the external side of the BBM and GGT is selectively
localized on the BBM, GSH synthesis occurs in the cytoplasm as GCL and GS are found
exclusively in the cytoplasm.

The highest concentration of GSH is found in the liver, which is the principal organ involved in
the detoxification and elimination of toxic materials. As shown in Figure 1-6, the process by
which GSH circulates throughout the body, which involves transport across plasma membranes
and translocation between tissues, is called „Interorgan metabolism‟ (Anderson et al., 1980;
Griffith and Meister, 1979a; Lash et al., 1988; McIntyre and Curthoys, 1980). Hepatic GSH is
transported out of the liver by transport across either the sinusoidal or canalicular plasma
membranes to plasma and bile, respectively (Ballatori and Dutczak, 1994; Kaplowitz et al.,
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1985). Biliary GSH is degraded to constituent amino acids in either the bile or small intestine
and the enterohepatic circulation returns these amino acids to the liver for resynthesis of GSH.
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Figure 1-5. Glutathione Synthesis.
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Figure 1-6. Interorgan transport and metabolism of GSH.
This scheme summarizes the pathways for transport, translocation between tissues and
metabolism of GSH and its metabolites involving the liver, kidneys, small intestine, bile and
plasma.
Abbreviations: BBM, brush-border membrane; BLM, basolateral membrane; CM, canalicular
membrane; SM, sinusoidal membrane.
From: Lash (2010).
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Plasma GSH is extracted by the kidneys by either glomerular filtration or basolateral uptake.
Even though liver is the primary source of GSH, the kidneys (predominantly PT cells) are the
major site for metabolism of GSH in the body. The kidneys play a central role in the overall
disposition of GSH in the body. Whereas the liver exhibits low activities of GSH uptake and
GGT for degradation of GSH, the kidneys play the major role in uptake and efflux of GSH,
synthesis of GSH from precursors, degradation of GSH and uptake of constituent amino acids
(Lash et al., 1988). The kidneys extract approximately 80% of the plasma GSH pool during a
single pass of the blood through the renal circulation (Griffith and Meister, 1979a; Haberle et al.,
1979). As shown in Figure 1-7, 50% of the GSH extracted occurs by a basolateral route whereas
30% of the extraction occurs by glomerular filtration.

Pathways of glutathione transport in renal proximal tubule

Plasma membrane GSH transport systems: Basolateral membrane (BLM) and brush
border membrane (BBM) transport

Basolateral plasma membrane transport: Renal PT cells obtain GSH from both extracellular
spaces by transport across the BLM and intracellular synthesis from precursor amino acids.

GSH uptake across the BLM of renal PT cells comprises two transport processes, a Na +-coupled
and a Na+-ion independent pathway. Current data suggest the potential involvement of three
carriers in the transport of GSH across the BLM of renal PT cells, the organic anion transporter 1
(Oat1; Slc22a6), organic anion transporter 3 (Oat3; Slc22a8), and the sodium-dicarboxylate
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carrier 3 (NaC3; Slc13a3; formerly known as sodium-dicarboxylate transporter 2 or SDCT-2).
As described in Figure 1-8, Oat1 and Oat3 function in the uptake of GSH in exchange for 2oxoglutarate (2-OG2-) and NaC3 functions in the co-transport of GSH with at least two Na+ ions.
Both Oat1 and Oat3 are broad-substrate specific organic anion transporters that are highly
expressed on the renal BLM. The functions of Oat1 and Oat3 account for the sodiumindependent uptake of GSH (Lash and Jones, 1983, 1984; Lash et al., 2007) and that of NaC3
accounts for the sodium-coupled uptake of GSH across the renal BLM. The (Na++K+)-stimulated
ATPase provides the Na+ ion gradient for transporters such as NaC3, thereby helping to provide
the driving force for uptake of GSH and other organic anions. Two multidrug resistance proteins,
Mrp5 (Abcc5) and Mrp6 (Abcc6), function in the ATP-dependent efflux of organic anions. In
addition to organic anion transporters, there are also organic cation transporters, such as Oct2
(Slc22a3) and Oct3 (Slc22a3) present on the BLM. Both Oct2 and Oct3 are uniporters for uptake
of organic cations (OC+).

Brush border plasma membrane transport: As shown in Figure 1-8, unlike BLM GSH transport,
the BBM process is not mediated by coupling to transport of any ion such as protons or Na + ions
and is predominantly efflux of intracellular GSH into the tubular lumen rather than uptake of
extracellular GSH into the cell. At the outer surface of the BBM, GSH is rapidly degraded to its
constituent amino acids such as cysteine, which is the rate-limiting component. Cysteine is taken
up by carriers on the BBM and is used for protein or GSH synthesis.

Although no direct evidence for a role for any specific carrier in the efflux of GSH across the
BBM has been demonstrated, the proposed carriers as mediators of GSH efflux are the organic
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Figure 1-7. Pathways for GSH transport and metabolism in renal proximal tubular cells.
Abbreviations: Cys, cysteine; DIC, dicarboxylate carrier; GCS, g-glutamylcysteine synthetase;
GSH, glutathione; GS, GSH synthetase; Oat1/3, organic anion transporters 1 and 3; DIC,
dicarboxylate carrier; OGC, oxoglutarate carrier.
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Figure 1-8. Schematic summary of renal plasma membrane transporters.
Major transporters for the uptake or efflux of OA– or OC+ on the BLM and BBM of PT cells are
illustrated. There are also the (Na++K+)-ATPase on the BLM and NHE on the BBM, which
provide ion or co-substrate gradients.
Abbreviations: BLM, basolateral membrane; BBM, brush-border membrane; Oat, organic anion
transporter; Mrp, multidrug resistance protein; Oct, organic cation transporter; Oat-k1/k2, kidney
specific organic anion transporter; NHE, sodium-hydrogen exchanger; GS–, Thiolate anion of
glutathione; OA–, organic anion; OC+, organic cation; 2-OG2–, 2-oxoglutarate; NaC3, sodiumcoupled carboxylate transporter; Oatp1, organic anion transporting polypeptide 1.
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anion transporting polypeptide 1 (Oatp1; Slco1a1) and two isoforms of the ATP-dependent
multidrug resistance proteins, Mrp2 (Abcc2) and Mrp4 (Abcc4). As described in Figure 1-8,
Oatp1, which is highly expressed on the BBM of the rat proximal tubule, has been shown in
other systems to mediate the efflux of GSH (Li et al., 1998; Mittur et al., 2002) and both Mrp2
and Mrp4 have been demonstrated to transport GSH (Evers et al., 2000; Gotoh et al., 2000; Lou
et al., 2003; Paulusma et al., 1999; Rebbeor et al., 2002 Rius et al., 2003). The BBM also
expresses three major carriers that function in the secretion of organic cations (OC +): Octn1
(Slc22a4), Octn2 (Slc22a5) and P-glycoprotein [P-gp]. Octn1 is an electroneutral exchanger of
OC+ with protons. Octn2 can function in either the facilitated efflux of OC + or as a Na+
ion/carnitine uptake cotransporter.

Significance of BLM and BBM GSH transport: Based on pharmacological and toxicological
studies, there are several potential functions for GSH transport across renal plasma membranes.
Previous studies provided in vivo evidence for renal tissue GSH uptake by orally administered
GSH (Aw et al., 1991; Flagg et al., 1994; Hagen et al., 1990). In addition, in vitro studies with
isolated renal PT cells showed that exogenous GSH increases intracellular GSH levels by BLM
transport and protected against various oxidants (Hagen et al., 1988; Lash and Tokarz, 1990;
Lash et al., 1996), suggesting significance of BLM GSH uptake in nephroprotection against
toxicants.

Even though there is some uncertainty in the literature regarding the precise physiological
function of GSH uptake across the renal BLM, the critical physiological importance of GSH
efflux across the renal BBM has been long appreciated (Lash, 2005, 2009). The BBM GSH

23

transport process is critical for turnover of whole body GSH as efflux of GSH into the lumen
mediates delivery of GSH to the active site of GGT on the surface of the BBM. The transport of
GSH across the BBM occurs with favorable driving forces including an outwardly-directly GSH
electrochemical gradient and high GGT activity on the BBM. Furthermore, previous studies
showed that inhibition of renal GGT activity in mice causes glutathionuria, suggesting the
importance of BBM efflux and GGT activity in GSH turnover (Griffith and Meister, 1979b).

Mitochondrial GSH status, transporters, and mechanisms of renal mitochondrial GSH
transport
There are two main cellular pools of GSH, one in the cytoplasm and the other in mitochondria
(Franco, 2007). The pH of cytoplasm is approximately 7.0 and that of the mitochondrial matrix is
approximately 7.8. Hence, the GSH pools are likely to each have a net charge of between -1 and
-2. As shown in Figure 1-9, GSH is synthesized in the cytoplasm and the predominant, if not
exclusive, location of enzymes catalyzing synthesis of GSH is the cytoplasm, suggesting that the
transport of GSH from the cytoplasm to mitochondria must occur to supply mitochondria with
GSH. We have shown previously that renal concentrations of GSH increase significantly after
uninephrectomy (Zalups and Lash, 1990). Because mitochondria lack enzymes for the synthesis
of GSH, what may cause an increase in mitochondrial GSH in PT cells from NPX rats? We
attempted to answer this question in two ways: First, by measuring rates of synthesis of GSH in
the cytoplasm and second, by measuring rates of transport of GSH from cytoplasm into
mitochondria. Our data showed that GCS activity was significantly higher in PT cells from NPX
rats than in PT cells from SHAM-operated (or control) rats (Lash and Zalups, 1994). These data
suggest that compensatory renal growth causes increases in the intracellular concentration of
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GSH by inducing synthesis from its precursors by GCS, which is the rate-limiting enzyme
involved in GSH biosynthesis. After the synthesis of GSH in cytoplasm, GSH is then transported
across the mitochondrial inner membrane into the matrix.

Mitochondria possess a membrane potential with the matrix space negative relative to the
cytoplasm and GSH is a negatively charged molecule at physiological pH. These facts suggest
that GSH must be transported actively or in exchange for another anion by mitochondrial anion
carriers. There are eight known anion carriers present in the mitochondrial inner membrane that
could play a role in the uptake of GSH from the cytoplasm (Table 1-1). These carriers are highly
active in cells such as those of the renal proximal tubule because of high rates of mitochondrial
respiration, active transport and gluconeogenesis (Lash, 2006). These mitochondrial carriers are
electroneutral in the sense that they mediate exchange of anions so that there is no net transfer of
charge across the inner mitochondrial membrane. Substrate specificity and energy dependence
studies in isolated rat kidney mitochondria (McKernan et al., 1991; Chen and Lash, 1998)
showed that two electroneutral anion exchange carriers, the dicarboxylate carrier (DIC,
Slc25a10) and 2-oxoglutarate carrier (OGC, Slc25a11) mediate most of the GSH uptake into
mitochondria. The function of each of these carriers is electroneutral, catalyzing the exchange of
anions across the inner membrane without any net transfer of charge. Furthermore, at least 80%
of GSH transport across the inner membrane of kidney mitochondria is due to the function of the
DIC and OGC (Chen and Lash, 1998, Chen et al., 2000). The function of these carriers in
transport of citric acid cycle intermediates suggests further that mitochondrial GSH status is
regulated by mitochondrial energetics.
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Figure 1-9. Mitochondrial GSH content and transport.
DIC, Dicarboxylate carrier; GS–, thiolate anion of glutathione; 2-OG2–, 2-oxoglutarate; OGC,
oxoglutarate carrier; Pi2-, inorganic phosphate.
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Table 1-1. Mitochondrial anion transporters.
From Lash (2006).
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A generalized scheme illustrating the functions of the DIC and OGC in GSH transport and their
relationship to both the citric acid and GSH redox cycles is shown in Figure 1-9. These two
carriers mediate the electroneutral exchange of GSH (in the form of GS 2–) with inorganic
phosphate and 2-OG, respectively. As both carriers are also involved in the transport of citric
acid cycle intermediates, amino acids and gluconeogenesis precursors (Klingenberg 1979;
Palmieri, 2004; Palmieri et al., 1996), this indicates that mitochondrial GSH status is influenced
by mitochondrial energy status. Both the DIC and OGC belong to a superfamily of mitochondrial
inner membrane transporters with similar three-dimensional structures as predicted by the
TMpred program. According to data from the TMpred program, the members of this superfamily
have three trans-membrane domains (TMDs). Each TMD is composed of two hydrophobic
stretches that span the membrane as α-helices, each separated by hydrophilic loops. Both the Nand C-terminals are in the cytoplasm. Both DIC and OGC are similar in size, with the DIC
containing 286 or 287 amino acids with a molecular weight of ~31 kDa and the OGC containing
314 to 322 amino acids with a molecular weight of 34-37 kDa, depending on species.

Significance of mitochondrial GSH transport in protection from oxidative stress
Mitochondria maintain redox balance and serve as the primary intracellular sites of generation of
reactive oxygen species (ROS). The redox status of mitochondrial GSH is known to be critical
for proper mitochondrial function. Alterations in GSH concentration and redox status are
associated with oxidative stress induced by peroxides and other oxidants in mitochondria from
kidney, liver, brain, tumor cells and activation of signaling pathways. In addition, previous
studies have shown that decreased concentration of mitochondrial GSH is associated with acute
toxicity (Lash and Anders, 1987) and apoptosis (Chen et al., 2001) in renal mitochondria and
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renal PT cells and depletion of the mitochondrial pool of GSH leads to several types of chemicalinduced toxicity such as oxidative stress (Shan et al., 1993; Fernandez-Checa et al., 1993). Thus,
maintenance of adequate concentrations of GSH within the mitochondrial matrix is essential for
regulation and proper function of many critical processes.

To explore the physiological and toxicological importance of mitochondrial GSH transport in a
well-defined renal cellular model system, the influence of modulation of mitochondrial GSH
status on cellular function and susceptibility to toxicants was studied in NRK-52E cells, an
immortalized cell line derived from normal rat kidney (Lash et al., 2002a). Our previous studies
showed that two mitochondrial carriers, the DIC and OGC, are responsible for at least 80% of
total transport of cytoplasmic GSH across the renal mitochondrial membrane (Chen and Lash,
1998; Chen et al., 2000). To further explore the role of these two carriers in GSH transport,
NRK-52E cells were transfected with cDNA for rat DIC, OGC and a double-cysteine mutant of
the OGC (Xu et al., 2006; Lash et al., 2002b). Overexpression of the DIC or OGC resulted in
5.5-fold and 6.1-fold increases in rates of mitochondrial GSH transport, respectively, as
compared to wild-type cells. In contrast, cells overexpressing the mutant OGC exhibited a
marked reduction in GSH transport as compared to wild-type cells.

To investigate the toxicological consequences of alterations in mitochondrial GSH transport,
NRK-52E cells were transfected with either nothing (WT) or cDNAs for the rDIC, rOGC or
rOGC-Mutant (Xu et al., 2006; Lash et al., 2002b). NRK-52E cells were incubated with either of
two mitochondrial toxicants, 10 µM tert-butyl hydroperoxide (tBH) and 50 µM S-(1,2dichlorovinyl)-L-cysteine (DCVC), to determine the fraction of cells undergoing apoptosis.
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Although both tBH and DCVC exhibit distinct mechanisms of action, both can cause lipid
peroxidation, GSH oxidation in mitochondria and apoptosis under appropriate conditions (Lash
et al., 2001a). The results showed that NRK-52E-DIC or NRK-52E-OGC cells exhibited
resistance to cell injury whereas NRK-52E-OGC-M cells exhibited similar sensitivity to tBH or
DCVC as the NRK-52E-WT cells. These results suggest that higher GSH transport activity by
overexpression of DIC and OGC markedly protected against apoptosis induced by either DCVC
or tBH, indicating the significance of mitochondrial GSH transport in determining susceptibility
to cytotoxic chemicals.

Goals of present study
Compensatory renal hypertrophy caused by a reduction in functional renal mass is associated
with a series of physiological, morphological and biochemical changes that also have
toxicological implications. As mentioned above, human clinical data also suggest health
complications due to reduced renal mass caused by renal donor nephrectomy. One of the
simplest experimental models for compensatory renal hypertrophy is the uninephrectomy rat
model (NPX model). In this NPX rat model, the right kidney is removed and compensatory renal
hypertrophy response is completed within 7-10 days and is maintained for at least 30 days
thereafter.

Previous studies showed that compensatory renal hypertrophy increases energy demand on PT
cells by increasing oxygen consumption and glucose production, leading to a hypermetabolic
state (Harris et al., 1988) that is associated with alterations in renal function and mitochondrial
status. Furthermore, previous studies showed that increased renal GSH content (Zalups and Lash,

30

1990) and higher susceptibility to nephrotoxicants (Lash et al., 2006) follow nephrectomy. These
observations suggest that increased renal GSH content is an adaptive response to an enhanced
basal oxidative stress that results from compensatory renal hypertrophy and susceptibility to
oxidant-induced injury increases because the increase in renal GSH content is insufficient to
maintain redox balance in the hypertrophied kidney cells. Interestingly, in 2002 and 2006 our lab
also showed that in NRK-52E cells, overexpression of mitochondrial GSH transporters protected
against nephrotoxicants (Lash et al., 2002b; Xu et al., 2006). These data suggested a possibility
that this approach can be used to protect hypertrophied kidney cells by further increasing renal
mitochondrial GSH content. Based on all these previous studies, we hypothesize that
compensatory renal hypertrophy after uninephrectomy alters renal function in vivo and
mitochondrial status. Further, we hypothesize that modulation of mitochondrial redox status
alters susceptibility to nephrotoxicants and oxidative stress in hypertrophied kidney cells. To
study these hypotheses, three specific aims of this study were conducted:

Aim 1. Determine the effect of compensatory renal hypertrophy on renal function including
physiological parameters and renal plasma membrane transporters.

Aim 2. Determine the effect of compensatory renal hypertrophy on mitochondrial status
including mitochondrial redox status, function, energetics, oxidative stress, size, number and
membrane potential.
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Aim 3. Manipulation of mitochondrial glutathione (GSH) by overexpression of mitochondrial
GSH carriers, DIC and OGC, to provide sustained increases in mitochondrial GSH content and
reduce susceptibility to nephrotoxicants in hypertrophied kidney cells.

Studies in Aim 1 and Aim 2 were conducted in vivo, in vitro and ex vivo to study renal function
and mitochondrial status. Studies in Aim 3 were done ex vivo using a primary cell culture model
with molecular approaches to study the effect of mitochondrial redox status on susceptibility of
PT cells to nephrotoxicants. In the nephron, glomerular and proximal tubular epithelium are the
most prominent sites that exhibit the various morphological, biochemical and functional changes
seen after uninephrectomy and compensatory renal growth. Our studies focus on the PT cells
because these cells play a major role in metabolite absorption and secretion and drug
metabolism. As a result, these PT cells are also a major target cells for drug-induced
nephrotoxicity and are most prominently affected in acute renal failure. Even though there are
numerous parameters of toxicity, changes in mitochondrial energetics and redox status appear to
be prominent components of the compensatory renal hypertrophy response. Hence, we primarily
focused on mitochondrial function and redox status.

Overall, our proposed research plan provides integrated approaches with in vivo, in vitro and ex
vivo models to further study renal function and mitochondrial energetics status, including redox
status and oxidative stress, and the influence of mitochondrial GSH on susceptibility to
chemically induced cytotoxicity. The significance of the present study lies in the occurrence of
reduction in functional kidney mass due to numerous diseases, surgery, aging and substantial
evidence that compensatory renal hypertrophy also increases the risks for development of health
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complications, renal insufficiency or renal failure from other diseases or environmental
exposures.
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CHAPTER II. MATERIALS AND METHODS

Animals
Surgical Procedures. Male Sprague-Dawley rats (150-175g) were used in the present study.
Animals that underwent surgical nephrectomy (removal of right kidney) were allowed a
minimum 10-day recovery period prior to experiments (Zalups and Lash, 1990). Right-side
nephrectomized rats were purchased from Harlan (Indianapolis, IN). The procedure they used is
as follows: Each rat was anesthetized with sodium pentobarbital (50 mg/kg i.p.) before surgery.
Unilateral nephrectomy was performed by making a 2.5-cm flank incision on the right side of the
body with a No. 11 scalpel blade, beginning at erector spinae muscles and continuing along the
angle of the 12th rib. The incision was made through the skin and underlying fascia. The
abdominal muscles were then incised along the same plane as the skin was cut to expose the
retroperitoneal region where the right kidney is situated. With blunt dissection, the right kidney
was exteriorized from the animal and the renal blood vessels and ureter were ligated with sterile
2.0 silk suture. The right kidney was then excised distal to the ligature. The abdominal muscles
were sewn together with 4.0 sterile silk suture and the opposite ends of the incised skin and
fascia were brought together with sterile 9-mm would clips. Control rats were surgically naïve,
because previous studies showed that sham surgery has no apparent effect on the compensatory
growth response (Zalups and Lash, 1990; Zalups, 1997; Lash et al., 1999). Control and NPX rats
were age-matched for all studies.
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Uninephrectomized Rat Model
In the uninephrectomized rat (NPX) model, the right kidney is removed and the compensatory
hypertrophy response is completed within 7-10 days after surgery (Zalups and Diamond, 1987;
Meyer et al., 1996). The experiments are done between day 10 and 30.

II-1 RENAL FUNCTION AND MITOCHONDRIAL STATUS
Chemicals
Cis-parinaric acid was purchased from Molecular Probes (Eugene, OR). Rotenone, tert-butyl
hydroperoxide (tBH), hemin and 1-methyl-2-phenylindole were purchased from Sigma-Aldrich
(St. Louis, MO). All other chemicals were of the highest purity available and were purchased
from commercial sources.

Methods

In vivo assessment of renal physiological parameters
Rats were kept in metabolic cages and urine samples were collected every 24 h for one week.
Basic parameters of renal function, including urine volume (U-Vol), urinary protein (U-Pr),
urinary-glutathione (U-GSH) and urinary glutathione disulfide (U-GSSG), urinary and serum
creatinine (U-Cr, S-Cr), urinary albumin (U-Alb), urinary N-acetyl- -D-glucosaminidase (UNAG) and urinary -glutamyltransferase (U-GGT) were measured.
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U-Pr (BCA protein assay kit from Pierce, Milwaukee, WI, U.S.A.), U-Cr and S-Cr
(QuantichromTM creatinine kit from BioAssay Systems, Hayward, CA, U.S.A.), U-Alb (Nephrat
ii kit from Exocell, Philadelphia, PA, U.S.A.), U-GSH and U-GSSG (GSH-Glo® kit from
Promega, Madison, WI, U.S.A.), and U-NAG (NAG assay kit from Diazyme, Poway, CA,
U.S.A.) were measured using commercial kits. U-GGT was measured by a spectrophotometric
assay (Orlowski and Meister, 1963).

Determination of protein expression of renal plasma membrane organic anion transporters
by Western blot analysis
Crude plasma membrane fractions were isolated according to the method of Scalera et al. (1981)
using a sucrose-triethanolamine (0.25 mM sucrose, 10 mM triethanolamine/HCl, pH 7.6, 0.1 mM
phenylmethylsulfonyl fluoride) buffer. Protein expression of organic anion transporters was
determined in isolated plasma membranes from kidney cortex derived from control and NPX rats
using commercially prepared antibodies. Polyclonal antibodies to organic anion transporter 1 and
3 (Oat1 and Oat3; Slc22a6 and Slc22a8, respectively) were purchased from Alpha Diagnostic
International (San Antonio, TX, U.S.A.). Monoclonal antibodies against multidrug resistanceassociated protein 2 and 5 (Mrp2 and Mrp5; Abcc2 and Abcc5, respectively) were purchased
from Abcam (Cambridge, MA, U.S.A.). Monoclonal antibody against Na +K+ATPase 1 subunit
was purchased from Affinity Bioreagents, Inc. (Golden, CO, U.S.A.). Secondary antibodies
(anti-rat, anti-rabbit, and anti-mouse) were purchased from Jackson ImmunoResearch (West
Grove, PA, U.S.A.). Polyclonal anti-actin antibody was purchased from Cell Signaling
Technology (Danvers, MA, U.S.A.) for use as a control for loading of total cellular protein.

36

Determination of protein expression of renal mitochondrial GSH transporters and redox
status proteins by Western blot analysis
Suspensions of isolated mitochondria were prepared from renal cortex from control and NPX
rats by differential centrifugation as follows: Rat kidneys were decapsulated and the medulla
removed. Kidneys were then placed in 15 ml of ice-cold buffer (225 mM sucrose, 10 mM
potassium phosphate, pH 7.4, 5 mM MgCl2, 20 mM KCl, 20 mM triethanolamine, pH 7.4, 0.1
mM phenylmethylsulfonyl fluoride, and 2 mM EGTA), homogenized, and centrifuged in 50 ml
polycarbonate centrifuge tubes at 600 x g (2250 rpm) for 10 min in a Sorvall SS34 rotor in a
Sorvall RC2B centrifuge. Supernatant was decanted and saved. The pellets containing tissue
fragments and mitochondria were washed with 30 ml of buffer and the resuspended material
centrifuged at 600 x g for 10 min. The supernatant fractions were combined and centrifuged at
15,000 x g for 5 min. The resultant pellet was resuspended in 2 ml of buffer without EGTA.
Protein expression of mitochondrial GSH transporters and redox enzymes were determined in
isolated mitochondria with commercially prepared antibodies. Specific proteins were visualized
by Enhanced Chemiluminescence (Pierce; Rockford, IL, U.S.A.). Monoclonal antibodies against
the 2-oxoglutarate carrier (OGC; Slc25a11) and prohibitin and polyclonal antibodies against the
dicarboxylate carrier (DIC; Slc25a10), superoxide dismutase 2 (Sod2) and the voltage-dependent
anion channel (VDAC or porin) were purchased from Abcam (Cambridge, MA, U.S.A.).
Polyclonal antibody against thioredoxin 2 (Trx2) was purchased from Santa Cruz Biotechnology
(Santa Cruz, CA, U.S.A.). Expression of VDAC or prohibitin was used as mitochondrial loading
controls.
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Analysis of gene expression by real-time PCR
Total RNA from the renal cortex was isolated using Trizol® (Invitrogen; Carlsbad, CA, U.S.A.).
First-strand cDNA was made from the isolated total RNA using a multiscribe reverse
transcriptase with random hexamers from Applied Biosystems (Foster City, CA, U.S.A.).
TaqMan Gene Assay kits containing primer/probe sets for Oat1 (GenBank accession no.
NM_017224), Oat3 (GenBank accession no. NM_031332), DIC (GenBank accession no.
NM_133418), OGC (GenBank accession no. NM_022398), and glyceraldehyde 3-phosphate
dehydrogenase (GAPDH; loading control; GenBank accession no. NM_017008.3) were
purchased from Applied Biosystems. All reactions were performed in triplicate. The relative
amounts of mRNA were calculated by using the comparative CT method.

Determination of mitochondrial GSH status
A fluorometric method (Hissin and Hilf, 1976) was used for determination of GSH and GSSG in
mitochondrial suspensions. GSH content was measured by the fluorescent product formed on
reaction with o-phthalaldehyde (OPT) with excitation at 350 nm and emission at 420 nm. GSSG
content was measured after treatment with N-ethylmaleimide, followed by reduction with
dithiothreitol and measurement of the fluorescent product formed with OPT.

Enzyme assays and protein determination
Activities of several GSH- and energy metabolism-related enzymes were measured in cytoplasm
and/or mitochondria from renal cortical homogenates from control and NPX rats.
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GSSG reductase assay:
GSSG reductase (GRD) activity was measured as NADPH oxidation by monitoring the decrease
in absorbance at 340 nm (ε = 6,220 M-1cm-1) as described by Bellomo et al. (1987).

GSH peroxidase assay:
GSH peroxidase (GPX) activity was measured with 25 mM H2O2 as substrate and was equated to
NADPH oxidation as detected by the decrease in absorbance at 340 nm (ε = 6,220 M -1cm-1)
according to Lawrence and Burk (1976).

GSH S-transferase assay:
GSH S-transferase (GST) activity was measured with 1-chloro-2,4-dinitrobenzene as substrate
and quantitation of S-2,4-dinitrophenyl-GSH formation by the increase in absorbance at 340 nm
(ε = 9,600 M-1cm-1) as described by Habig et al. (1974).

Glutamate dehydrogenase assay:
Glutamate dehydrogenase (GDH) activity was measured spectrophotometrically by coupling 2oxoglutarate reduction to NADH oxidation as described by Schmidt and Schmidt (1983). The
oxidation of NADH was coupled to the reduction of 2-oxoglutarate to glutamate according to the
following reaction:
2-oxoglutarate + NADH + NH4

glutamate + NAD+ + H2O

The activity was quantified by determining the consequent decrease in absorbance at 340 nm
using an extinction coefficient of 6,220 M-1cm-1 for NADH.
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Malic dehydrogenase assay:
Malic dehydrogenase (MDH) activity was measured as described by Ochoa (1955). The
oxidation of NADH was coupled to the reduction of oxaloacetate to malate according to the
following reaction:
Oxaloacetate + NADH + H+

L-Malate + NAD+

The activity was determined by monitoring the decrease in absorbance at 340 nm (ε = 6,220 M1

cm-1).

Succinate: cytochrome c oxidoreductase assay:
Succinate: cytochrome c oxidoreductase (SDH) activity was measured as described by Fleischer
and Fleischer (1967). The oxidation of succinate to fumarate was coupled to reduction of
ferricytochrome c to ferrocytochrome c according to the following reaction:
Succinate + 2- ferricytochrome c

fumarate + 2-ferrocytochrome c

The activity was quantified by determining the increase in absorbance at 550.5 nm using an
extinction coefficient of 18,500 M-1cm-1 for reduced cytochrome c.

Protein Determination:
Protein content of samples was determined by the bicinchoninic acid (BCA) protein assay
method using bovine serum albumin as a standard (Bradford, 1976).
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Mitochondrial oxygen consumption
Oxygen consumption was measured in suspensions of isolated renal cortical mitochondria from
control and NPX rats with a Gilson 5/6H Oxygraph in a thermostated, air-tight, 1.6 ml chamber
at 25˚C (Lash et al., 2001a). State 3 rates of oxygen consumption were measured by the addition
of 0.3 mM ADP and respiratory substrate (3.3 mM succinate in the presence of 5 μM rotenone)
for coupling site II to the chamber containing 0.5 ml of mitochondrial sample and 1 ml
mitochondrial buffer. State 4 rates of oxygen consumption were measured after depletion of
ADP. Respiratory control ratio (RCR = State 3/State 4) was then calculated.

Mitochondrial Proteomics
Two mitochondrial samples of renal cortical homogenates from control and NPX rat group were
used. An aliquot (100 µg) of each mitochondrial extract was reduced with DTT, alkylated with
iodoacetamide and digested with trypsin overnight at 37˚C. Each of the samples was labeled with
a unique isobaric iTRAQ tag (Applied Biosystems): Control-114 (tag), NPX-115 (tag). The
samples were combined and purified by strong cation exchange chromatography using the SCX
Methods Development Kit (Applied Biosystems). Each sample was dried and resuspended in
water (2 cycles), then dried and resuspended in 2% acetonitrile, 0.1% TFA.

Peptides were separated by reverse phase chromatography (Magic C18 column, Michrom).
Peptides were ionized with the ADVANCE ion source (Michrom) and introduced into a LTQXL mass spectrometer (Thermo Fisher Scientific). Abundant species were fragmented in PulsedQ Dissociation mode (PQD). 5 LC/MS/MS runs were performed, 3 short and 2 long, on the same
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sample. Data analyses were performed twice using SEQUEST, X!Tandem and Mascot search
engines. A rat protein database (IPI ver 3.47) was used for the analysis.

Relative quantitation:
115/114: average signal intensity (NPX) / average signal intensity (Control)

The proteomics work was done at the Proteomics Core Facility of the Institute of Environmental
Health Sciences at Wayne State University, School of Medicine.

Assessment of basal and toxicant-induced mitochondrial oxidative stress

Lipid peroxidation by malondialdehyde assay
One method for assessment of lipid peroxidation was measurement of malondialdehyde (MDA)
formation using 1-methyl-2-phenylindole (Gérard-Monnier et al., 1998). Mitochondrial
suspensions (200 μl) were treated with tBH (500 μM) or buffer for 1 h at 37˚C and then
hydrolyzed using 0.1 M HCl and incubated for 60 min at 60˚C. An aliquot (200 μl) of the
resulting supernatant was then incubated with 650 μl 1-methyl-2-phenylindole and 150 μl 37%
HCl. After incubating the mixture for 30 min at 45˚C, absorbance at 586 nm was determined.

Lipid peroxidation by cis-parinaric acid fluorescence assay
Cis-parinaric acid is considered a very sensitive marker for the initial stages of lipid peroxidation
(Tribble et al., 1994). Isolated mitochondria (1 mg protein/ml) were incubated on ice with 6.4
μM cis-parinaric acid for 15 min. After pelleting mitochondria (11,200 g x 5 min) and discarding
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the supernatant, mitochondria were resuspended (0.5 mg protein/ml) in mitochondrial buffer. For
anaerobic conditions, mitochondria were resuspended in mitochondrial buffer (prepared with
nitrogen sparging) and treated with 5 μM hemin (Fe2+). Samples were then added to a 24-well
plate and incubated at room temperature for 10 min before treatment with tBH or buffer. Lipid
peroxidation was measured as the loss of cis-parinaric acid fluorescence (excitation 324 nm,
emission 413 nm) over time using a fluorescence plate reader (Tribble et al., 1994; Murphy et al.,
2003).

Mitochondrial aconitase activity
Aconitase activity was assayed by following formation of NADPH at 340 nm at 25˚C, as
described by Han et al. (2003). The reaction mixture contained 30 mM Tris-HCl, pH 7.4, 30 mM
sodium citrate, 0.6 mM MnCl2, 0.2 mM NADP+, 1 U/ml isocitrate dehydrogenase and 0.1 mg of
mitochondrial protein.

Analysis of oxidative stress markers by Western blot analysis
Proteins modified with 3-nitrotyrosine (3-NT) or 4-hydroxy-2-nonenal (HNE) were also assessed
as markers of oxidative alterations in renal mitochondria. Monoclonal antibody to 3-NT was
purchased from Abcam (Cambridge, MA, U.S.A.). Polyclonal antibody to HNE was purchased
from Calbiochem (La Jolla, CA, U.S.A.).
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Effect of toxicant (tBH) on mitochondrial protein expression during compensatory renal
hypertrophy
Mitochondrial samples from control and NPX groups were treated with 10 µM tBH for 1h at
37oC. Each of the samples was labeled with a unique isobaric iTRAQ tag (Applied Biosystems):
Control-116 (tag), NPX-117 (tag). The samples were processed as described previously in the
mitochondrial proteomics section.

Relative quantitation:
117/115: average signal intensity (NPX-tBH) / average signal intensity (NPX)
116/114: average signal intensity (Control-tBH) / average signal intensity (Control)
117/116: average signal intensity (NPX-tBH) / average signal intensity (Control-tBH)

Data analysis
Data for enzyme assays were normalized to the content of cellular protein. All measurements
were performed at least 3 to 5 times. Results are expressed as means ± SEM unless specified.
Densitometry of bands on Western blots were performed using GelEval 1.22 software for Mac
OS X. When two or more parameters were varied and compared (e.g., tBH treatment vs. buffer
in control and NPX rats), significant differences among means for data were first assessed by a
one-way analysis of variance. When significant “F values” were obtained, the Fisher‟s protected
least significance t test was performed to determine which means were significantly different
from one another, with two-tail probabilities < 0.05 considered significant. Otherwise, Student‟s
t-test was performed to determine which means were significantly different from one another,
using a two-tail probability of P < 0.05 as the criteria for significance.
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II-2 STUDIES IN PROXIMAL TUBULAR CELL PRIMARY CULTURES

Chemicals
Percoll, collagenase (type I; EC 3.4.24.3), type I collagen, bovine serum albumin (fraction V),
penicillin G, streptomycin, amphotericin B, insulin (from bovine pancreas), human transferrin,
sodium selenite, hydrocortisone, epidermal growth factor (EGF; from mouse submaxillary
glands), and 3,3‟,5-triiodo-DL-thyronine (T3) were purchased from Sigma Chemical Co. (St.
Louis, MO). Dulbecco‟s modified Eagle‟s medium/Ham‟s F-12 (DMEM/F-12, 50/50, 1X) was
purchased from Mediatech Inc. (Herndon, VA). Polystyrene tissue culture dishes were purchased
from Corning Inc. (Corning, NY). Polypropylene micromesh (210 µm pore size) was purchased
from SpectraPor Inc. (Rancho Dominguez, CA).

Culture of rat proximal tubular cells
Isolated renal cortical cells were obtained by collagenase perfusion (Jones et al., 1979). A day
before perfusion, all the glassware and surgical tools were sterilized in an autoclave. On the day
of perfusion, Hank‟s concentrate (5X) containing 137 mM NaCl, 5.4 mM KCl, 0.81 mM
MgSO4.7H2O, 0.42 mM Na2HPO4, 0.44 mM KH2PO4 and 25 mM NaHCO3 was used to make
Hank‟s I (25 mM Hepes, 0.5 mM EGTA and 2% (w/v) BSA) and Hank‟s II (4 mM CaCl2 and
0.15% (w/v) collagenase) buffers. Krebs-Henseleit Concentrate #1 (2X) containing 118 mM
NaCl, 4.8 mM KCl, 0.96 mM KH2PO4, 1.2 mM MgSO4.7H2O, 25 mM NaHCO3 and 2.55 mM
CaCl2.2H2O was used to make KHB-1 buffer. Krebs-Henseleit Concentrate #2 (10X) containing
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118 mM NaCl, 4.8 mM KCl, 0.96 mM KH2PO4, 1.2 mM MgSO4.7H2O and 25 mM NaHCO3
and 25 mM Hepes was used to make KHB-II buffer. All buffers were bubbled with 95% O2/5%
CO2 for 30 min and adjusted to pH 7.40.

Rats were anaesthetized with an intraperitoneal injection of sodium pentobarbital (50 mg/kg
body weight) and injected with 0.3 ml heparin into the tail vein. After sterilizing abdominal walls
with 70% (v/v) ethanol, the peritoneal cavity was opened by a midventral incision and the aorta
was freed below and above the renal arteries. One ligature with 4-O silk was placed below the
renal arteries and a second one was placed right below the liver. To avoid leakage of the
perfusion fluid, mesenteric arteries (coeliac and superior) are ligated. A small incision is made in
the aorta above the lower ligature and a 19-gauge conical probe cannula is inserted and closed
with a clamp and a ligature. The perfusion of kidneys is started in situ using Hank‟s I buffer
maintained at 37˚C. Once kidneys become pale, Hank‟s I buffer is replaced by Hank‟s II buffer
maintained at 37˚C. After a few minutes of perfusion, the kidneys are excised from the posterior
abdominal wall and transferred to beaker containing Hank‟s II buffer.

After circulating the buffer for 20 min at a flow rate of 5 ml/min, the kidneys are dispersed with
a pair of forceps into KHB-1 buffer containing 25 mM Hepes and 2% (w/v) BSA. The digested
renal mixtures were filtered through a 210 m polypropylene micromesh from SpectraPor Inc.
(Rancho Dominguez, CA), and then the filtrates were centrifuged for 2 min at 50 rpm at room
temperature. The pellets were resuspended in KHB-II buffer and 5 ml of cortical cells were
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layered on 35 ml of Percoll solution in 50-ml polycarbonate centrifuge tubes. After centrifuging
both tubes at 4˚C for 30 min at 12,900 rpm in a SS34 rotor in a Sorvall RC2B centrifuge, the
upper layers of cells, which are PT cells, were taken out. The PT cells were diluted with
DMEM/F-12 (50/50, 1X) media supplemented with 5 µg/ml insulin, 100 ng/ml Hydrocortisone,
100 ng/ml EGF, 5 µg/ml transferrin, 30 nM sodium selenite, 7.5 pg/ml triidothyronine, 100x
antibiotics (penicillin, streptomycin and amphotericin B). The cells were seeded onto collagencoated, 35-mm polystyrene tissue culture dishes at a density of 2 to 4 x 10 6 cells/ml. Media were
changed the next day and every other day thereafter. On day 4 of culture, the cells were
processed.

MitoTrackerTM orange staining
On day 4 of primary culture, the PT cells were stained with MitoTrackerTM orange (50 nM) for
30 min. The cells were viewed with a Zeiss LSM-510 META NLO Laser Scanning Confocal
Microscope at 554 nm excitation and 576 nm emission using 630x magnification. Three images
of each group were quantitated by using Metamorph 7.1.7.0 Offline (Molecular Devices,
Sunnyvale, CA) with measurement of integrated intensity of the entire image. Average intensity
(intensity/µm) of three confocal images from each group was then calculated.
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JC-1

(5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethylbenzyimidazolyl-carbocyanine

iodide)

staining
On day 4 of primary culture, PT cells were stained with JC-1 (5 µg/ml) for 30 min. The cells
were analyzed with a LSM-510 META NLO Laser Scanning Confocal Microscope using an
overlay of images in red (488 nm excitation, 590 nm emission, polarization) and green (488 nm
excitation, 525 nm emission, depolarization) using 630x magnification. Three images of each
group were quantitated by using Metamorph 7.1.7.0 Offline (Molecular Devices, Sunnyvale,
CA) with measurement of integrated intensity of the entire image. Average intensity
(intensity/µm) of three confocal images from each group was then calculated.

Confocal Microscopy
The confocal work was done at the Microscopy, Imaging and Cytometry Resources Core at
Wayne State University, School of Medicine (Detroit, MI).

DNA fluorescence assay
DNA was purified from renal mitochondria from control and NPX rats using the SV genomic
DNA purification system (Promega, Madison WI). Mitochondrial DNA was measured by a DNA
fluorescence assay (Sorger and Germinario, 1983). Relative fluorescence of the DNA-DAPI
complex was measured with a SpectraMax M2 plate reader set to 360 nm excitation and 450 nm
emission. A concentrated DAPI stock solution (1 mg/ml in water) was wrapped in foil and stored
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at 0-4˚C. A DAPI working solution (2.5 µg/ml) was prepared by bringing 1 ml of DAPI stock
solution (1 mg/ml) to 400 ml with assay buffer (18 mM Na2SO4 in 50 mM Hepes, pH 7.0).

Standards were prepared containing 0.25-2.5 µg DNA/ml, 200 µg BSA/ml and 10 µl/ml of 1 M
NaOH in 0.2% Triton X-100. Aliquots of standards and mitochondrial samples were added to
disposable glass tubes and 2.5 ml of DAPI reagent (0.4 volumes of DAPI working solution (2.5
µg/ml), 3.6 volumes of assay buffer, 6 volumes of water) was added to each tube. After 90 min
of incubation at room temperature, relative fluorescence was measured.

Mitochondrial protein assay
Protein content of renal mitochondrial samples was determined by the bicinchoninic acid (BCA)
protein assay method using bovine serum albumin as a standard (Pierce Rockford, IL).

Transfection
DIC cDNA that was cloned into pcDNA 3.1/V5-His-TOPO vector (Lash et al., 2002b) and
cDNA encoding OGC that was cloned into pcDNA 3.1/V5-His-TOPO vector (Xu et al., 2006)
were purified using Maxiprep (Promega, Madison WI).
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On day 3 of primary culture, cells were transfected with purified DIC and OGC plasmids with
final concentration of 800 ng plasmid DNA/well of Dulbecco‟s modified Eagle‟s medium using
LipofectamineTM and PLUSTM reagents (Invitrogen; Carlsbad, CA, U.S.A.).

Gene expression by real-time PCR
Total RNA was isolated on day 6 of cell culture (72 h post-DIC transfection) from cell culture of
rat PT cells using Trizol® (Invitrogen; Carlsbad, CA, U.S.A.). First-strand cDNA was made from
the isolated total RNA using a multiscribe reverse transcriptase with random hexamers from
Applied Biosystems (Foster City, CA, U.S.A.). Taq Man gene assay kits containing primer/probe
sets for DIC (GenBank accession no. NM 133418), OGC (GenBank accession no. NM 022398)
and glyceraldehyde 3-phosphate dehydrogenase (GAPDH, GenBank accession no. NM
017008.3) were purchased from Applied Biosystems. The fold change of genes was calculated
by the 2∆CT formula where 2 is used assuming a doubling in every cycle.

Assay for assessment of cytotoxicity
Necrotic cell death was measured in PT cells by measurement of lactate dehydrogenase (LDH)
release. On day 6, suspensions of PT cells were treated with either antimycin A (1 µM, 10 µM),
tBH (100 µM, 200 µM) or MVK (100 µM, 200 µM) for 4 h with or without an overnight
preincubation with 5 mM GSH. After 4 h, aliquots were removed and LDH activity was
measured. LDH activities in supernatant and cells were measured spectrophotometrically as
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NADH oxidation at 340 nm after addition of 3 mg/ml pyruvate and 3 mg/ml NADH. Percentage
of LDH release was calculated using the formula:
% LDH release = [LDH activity in media/(LDH activity in media + LDH activity in cells)] x
100%

Data analysis
Results are expressed as means ± SE values of measurements from the indicated number of cell
preparations. Significant differences among selected mean values were calculated using
Student‟s t-test with P values ≤ 0.05 as the criteria for significance.
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CHAPTER III. RENAL FUNCTION

Renal physiological parameters in vivo

Results
Examination of basic parameters of renal function indicates that there are some discernable
changes in rats post-nephrectomy compared to age-matched control rats (Table 3-1). After
uninephrectomy and a 10-day period to allow for completion of the acute phase of compensatory
growth, the remaining kidney weighs significantly more than a single kidney from control rats.
NPX animals had markedly higher urine volume, indicating an increase in renal function to
compensate for the loss of a kidney. However, we also observed increases in total urinary protein
(U-Pr), urinary albumin (UAlb), serum creatinine (S-Cr), urinary N-acetyl- -D-glucosaminidase
(U-NAG), urinary -glutamyltransferase (U-GGT) and urinary glutathione disulfide (U-GSSG),
but lower urinary creatinine (U-Cr) over a 24-h period and lower creatinine clearance (CCr),
indicating significant impairment of renal function.
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Table 3-1. Physiological parameters of renal function in vivo.
Parameters were measured in uninephrectomized (NPX) rats at 10 days post-surgery and in agematched control rats. Results are means ± SEM of measurements from the indicated number of
rats from each group.

Parameter (units; n)

Control

NPX

Kidney Weight (g; 10)

0.95 ± 0.04

1.51 ± 0.06*

U-Vol (ml; 6)

3.08 ± 0.47

8.43 ± 1.63*

U-Pr (mg/24 h; 6)

11.1 ± 1.5

34.9 ± 3.2*

S-Cr (mg/dl; 3)

0.09 ± 0.04

0.24 ± 0.06*

U-Cr (mg/dl; 3)

168 ± 7

93.6 ± 11.2*

U-Cr (mg/24 h; 3)

7.63 ± 0.48

5.43 ± 0.30*

CCr (ml/min; 3)

6.67 ± 0.80

2.00 ± 0.54*

U-Alb (mg/24 h; 3)

150 ± 10

860 ± 110*

U-GSSG (nmol/24 h; 6)

1.53 ± 0.73

9.51 ± 0.32*

U-NAG (U/24 h; 9)

0.07 ± 0.01

0.14 ± 0.03*

U-GGT (mU/24 h; 6)

197 ± 9

327 ± 30*

Abbreviations: U-Vol, urinary volume; U-Pr, urinary protein; S-Cr, serum creatinine; U-Cr,
urinary creatinine; CCr, creatinine clearance; U-Alb, urinary albumin; U-GSSG, urinary
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glutathione disulfide; U-NAG, urinary N-acetyl- -D-glucosaminidase; U-GGT, urinary

-

glutamyltransferase. *Significantly different (P<0.05) from the corresponding value in control
rats.
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Discussion
The major underlying hypothesis to explain the physiological and pathological changes that
occur in remnant renal tissue as a consequence of compensatory renal hypertrophy begins with
the increased need for renal function requiring increased mitochondrial electron transport to
generate ATP (Meyer et al., 1996; Harris et al., 1988; Nath et al., 1990; Shapiro et al., 1994). As
a consequence of this increase in mitochondrial function, more reactive oxygen species are
generated, which in turn leads to a higher level of renal oxidative stress, further leading to
increased susceptibility of renal PT cells from NPX rats to nephrotoxicants.

The present study not only confirmed the increase in kidney weight and urine production that
accompany the compensatory response of the remnant kidney after uninephrectomy, but also
provided evidence at the in vivo level that this compensation is associated with some degree of
renal damage. Several markers, which are all considered diagnostic for renal function, were
uniformly altered in a manner consistent with mild renal injury. Evidence for renal injury at the
level of the PT cell was also observed by the increases in U-NAG and U-GGT. We also observed
a 6.2-fold increase in U-GSSG, which may indicate some amount of oxidative damage in the
kidneys. Compared to normal conditions in which creatinine is filtered and proteins usually do
not cross the glomerular membrane, compensatory renal hypertrophy decreases creatinine
clearance but increases protein secretion. Previous studies have shown that proteinuria is also
correlated with intrinsic renal toxicity and contributes to progression of renal damage (Bertani et
al., 1986). The compensatory renal hypertrophy also decreases the ability to conserve ions,
bicarbonate and water, leading to increases in urine volume. This suggests increased renal
function to compensate for the reduction in nephron mass.
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Our data are also consistent with previous animal studies that suggested that glomerular
hypertension and glomerular hyperfiltration lead to pathogenesis of proteinuria and progressive
glomerulosclerosis (Hostetler et al., 2001). Overall, our data also suggest some clinical
implications such as proteinuria, microalbuminuria and hypertension, which is consistent with
data from human clinical studies that are investigating the quality of life of renal transplant
donors (Berber et al., 2008; Tellioglu et al., 2008; Azar et al., 2007).
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Protein and gene expression analysis of renal plasma membrane organic anion
transporters.

Results
Based on previous observations of increases in intracellular GSH concentrations and GSH
transport activity after compensatory renal hypertrophy (Zalups and Lash, 1990; Lash et al.,
2001b), we hypothesized that these increases were due, at least in part, to increases in gene
and/or protein expression of carriers involved in GSH transport across renal plasma membranes.
To test this, we determined mRNA and protein expression of four renal plasma membrane
transporters that are known or thought to be involved in GSH transport. Real-time PCR analysis
of Oat1 and Oat3 mRNA expression (Table 3-2) revealed no differences between control and
NPX rats. In contrast, Western blot analyses of Oat1 and Oat3 protein levels showed nearly 2fold increases in protein expression for both carriers in kidneys of NPX rats as compared to those
of control rats (Figure 3-1).

Additionally, expression of two Mrp carriers that can transport GSH were examined. Whereas
protein expression of Mrp2, which is localized to the BBM, was increased by approximately
30% in NPX rat kidneys as compared to that in control rat kidneys, expression of Mrp5, which is
localized to the BLM, was unchanged. Inasmuch as both Oat1 and Oat3 are believed to mediate
uptake of GSH into the renal PT cell whereas both Mrp2 and Mrp5 mediate efflux from the cell,
the larger increase in Oat1/3 compared to that for Mrp2 are consistent with higher intracellular
accumulation of GSH. We also examined protein expression of the (Na+ + K+)-ATPase, which
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provides the major driving force for many secondary active transport carriers; its expression was
also found to be significantly higher (1.4-fold) in kidneys of NPX rats as well.

58

Figure 3-1. Effect of compensatory renal growth on protein expression of renal plasma
membrane organic anion transporters and the (Na+ + K+)-stimulated ATPase.
Protein expression of Oat1, Oat3, Mrp2, Mrp5 and the (Na + + K+)-stimulated ATPase were
determined by Western blot analysis as described in Section 2. -Actin protein was used as a
loading control. Blots were scanned and quantified by densitometry using GelEval 1.22 software.
Data represent means ± SEM of measurements from renal homogenates from three control and
three NPX rats. *Significantly different (P < 0.05) from corresponding control sample.
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Table 3-2. Real-time quantitative PCR analysis of Oat1, Oat3 mRNA expression in renal
cortex of control and NPX rats.
Primers were designed with the aid of Oligo 6.76 and the cDNA sequences published in
GenBankTM. Primer and labeled probe sets were from Applied Biosystems. An optimum cDNA
concentration of 30–300 ng DNA/well was determined for each gene. All CT values are based on
the measurements of total RNA samples from kidney cortex of both control and NPX rats and
are means ± SEM. GAPDH CT values were used for correction: For Oat1 and Oat3 samples,
GAPDH CT values = 30.3 ± 0.2 for control rats and 30.4 ± 0.3 for NPX rats. Relative gene
expression values were calculated by the formula: 2-∆CT

(NPX)

/ 2-∆CT

(Control)

, ∆CT value is the

difference between the CT value for the gene of interest and that of GAPDH.

Gene

Control

NPX

Relative Expression

CT mean ± SE

CT mean ± SE

Oat 1 (Slc22a6)

31.4 ± 0.3

32.0 ± 0.8

0.75

Oat 3 (Slc22a8)

32.4 ± 0.1

32.8 ± 0.5

0.86

(NPX / Control)
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Discussion
A longstanding observation is that compensatory renal hypertrophy is associated with a
significant increase in total cellular GSH content compared to that in kidneys from control rats,
particularly in the PT region of the nephron (Zalups and Lash, 1990). We previously showed that
compensatory renal hypertrophy is associated with higher activity of

-glutamylcysteine

synthetase (GCS) (Lash and Zalups, 1992, 1994; Lash et al., 2001b). While higher GCS activity
could certainly be one mechanism for the increase in the cytoplasmic pool of GSH, increased
transport across the BLM of plasma or renal periplasma GSH is also another potential
mechanism. Thus, increase in the activity and/or expression of the plasma membrane carrier
proteins that are responsible for GSH transport into the PT cell may also help explain some of
the data.

Despite the lack of a clear understanding of the physiological role(s) for uptake of GSH into the
renal PT cell, several candidate carrier proteins have been identified (Lash, 2005, 2009; Lash et
al., 2007). These include Oat1, Oat3, and the sodium-dicarboxylate 3 (NaC3; Slc13a3) carriers
on the renal BLM. Additionally, both Mrp2 and Mrp5 can mediate efflux of GSH out of the renal
PT cell across the BBM and BLM, respectively. The present study demonstrated significantly
higher protein expression (~ 2-fold increases) for both Oat1 and Oat3 in renal homogenates from
NPX rats. Whereas no difference was observed between Mrp5 expression in renal homogenates
from control and NPX rats, Mrp2 protein expression was modestly (~ 50%) higher in renal tissue
from NPX rats. Thus, although there is higher efflux by Mrp2, the increases in uptake by Oat1
and Oat3 would seem to predominate, thereby leading to higher intracellular accumulation of
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GSH. These results are consistent with our previous finding of higher activity of both Oat1 and
Oat3 in renal BLM vesicles from NPX rats as compared to those from control rats (Lash et al.,
2005).

Expression of these Oat carriers at the mRNA level was also determined by real-time PCR.
Despite our expectation that mRNA levels of the Oat carriers would be higher in kidneys of NPX
rats, we found no differences between kidneys of the two groups of rats. This indicates that the
changes in the plasma membrane carriers that occur as a consequence of compensatory renal
growth are post-transcriptional and/or post-translational, and probably involve a combination of
effects, including increased mRNA translation, increased protein stability, and/or decreased
protein degradation.
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CHAPTER IV. MITOCHONDRIAL STATUS
Mitochondrial redox status

Results
To determine whether or not compensatory renal hypertrophy causes alterations in renal
mitochondrial redox status, we first measured mitochondrial GSH (reduced glutathione) and
GSSG (glutathione disulfide) levels in renal mitochondria from both control and NPX rats.
Modest, but significant increases were observed in concentrations of both GSH and GSSG in
renal mitochondria from NPX rats as compared to those from control rats (Table 4-1).

Inasmuch as GSH status in renal mitochondria is determined primarily, if not entirely, by the
function of two inner membrane carrier proteins, the DIC and OGC (Chen and Lash, 1998; Chen
et al., 2000), we next determined gene and protein expression of these carriers. Because previous
work (Lash et al., 2001a) showed markedly higher rates of GSH uptake by renal mitochondria
from NPX rats as compared to those from control rats, we expected to see increases in
expression of these carrier proteins. Despite this expectation, neither mRNA (Table 4-2) nor
protein (Figure 4-1) expression of either the DIC or OGC were elevated in renal mitochondria
from NPX rats as compared to those in renal mitochondria from control rats. Besides the GSH
system, redox status in mitochondria is also regulated by two other enzymes, superoxide
dismutase 2 (Sod2) and thioredoxin 2 (Trx2). Measurements of protein expression of Sod2 and
Trx2 (Figure 4-2), however, showed no significant differences between renal mitochondria of
control and NPX rats.
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Table 4-1. GSH and GSSG concentrations in renal mitochondria from control and NPX
rats.
Mitochondrial GSH and GSSG levels were measured in suspensions of isolated mitochondria
from rat renal cortex from control and NPX rats using a fluorometric method. Results are
nmol/mg protein and are means ± SEM of measurements from three rats from each group.

Parameter

Control

NPX

GSH

1.67 ± 0.08

1.97 ± 0.05*

GSSG

0.90 ± 0.04

1.05 ± 0.02*

* Significantly different (P<0.05) from the corresponding value in control rats.
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Figure 4-1. Effect of compensatory renal growth on protein expression of renal
mitochondrial GSH transporters.
Mitochondrial samples were isolated from rat kidney cortex of control (CON) and
uninephrectomized (NPX) rats and subjected to immunoblotting with anti-DIC, -OGC and VDAC. The VDAC protein served as a mitochondrial loading control. Note that the OGC protein
was detected as both monomers (Mr = 32.5 kDa) and a dimer (Mr = 65 kDa). Blots were scanned
and quantified by densitometry using GelEval 1.22 software. Data represent means ± SEM of
measurements from renal mitochondrial samples from three CON and three NPX rats. No
significant differences were detected between corresponding CON and NPX samples.
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Table 4-2. Real-time quantitative PCR analysis of DIC and OGC mRNA expression in
renal cortex of control and NPX rats.
Primers were designed with the aid of Oligo 6.76 and the cDNA sequences published in
GenBankTM. Primer and labeled probe sets were from Applied Biosystems. An optimum cDNA
concentration of 30–300 ng DNA/well was determined for each gene. All CT values are based on
the measurements of total RNA samples from kidney cortex of both control and NPX rats and
are means ± SEM. GAPDH CT values were used for correction: For DIC and OGC samples,
GAPDH CT values = 30.3 ± 0.2 for control rats and 30.4 ± 0.3 for NPX rats. Relative gene
expression values were calculated by the formula: 2-∆CT

(NPX)

/ 2-∆CT

(Control)

, ∆CT value is the

difference between the CT value for the gene of interest and that of GAPDH.

Gene

Control

NPX

Relative Expression

CT mean ± SE

CT mean ± SE

DIC (Slc22a10)

32.9 ± 0.2

33.4 ± 0.4

0.78

OGC (Slc22a11)

33.6 ± 0.3

33.9 ± 0.1

0.89

(NPX / Control)
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Figure 4-2. Effect of compensatory renal growth on protein expression of renal
mitochondrial Sod2 and Trx2.
Mitochondrial samples were isolated from rat kidney cortex of control (CON) and
uninephrectomized (NPX) rats and subjected to immunoblotting with anti-Sod2, anti-Trx2, and
anti-prohibitin. The prohibitin protein served as a mitochondrial loading control. Blots were
scanned and quantified by densitometry using GelEval 1.22 software. Data represent means ±
SEM of measurements from renal mitochondrial samples from three CON and three NPX rats.
No significant differences were detected between corresponding CON and NPX samples.
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Discussion
Although most of the GSH detected when one measures total cellular content resides in the
cytoplasm, changes in the status of GSH in the mitochondrial pool would also be expected to
occur. Such changes in mitochondrial GSH content have important impacts on mitochondrial
function, cellular energetics, and ultimately cell viability (Lash et al., 1998). The present study
demonstrated a significantly higher level of GSH specifically in renal mitochondria from NPX
rats as compared to those from control rats. Because GSH synthesis in the renal PT cell only
occurs in the cytoplasm (McKernan et al., 1991), transport of GSH across the mitochondrial
inner membrane would appear to be the sole source of GSH for the mitochondrial matrix. In the
renal cortex and PT cell, the DIC and OGC are the two carriers we identified as being
responsible for this transport process (Chen and Lash, 1998; Chen et al., 2000). The functional
importance of this renal mitochondrial GSH pool has been demonstrated in studies in which
genetic manipulation of DIC or OGC expression markedly altered redox status and susceptibility
to oxidants and other nephrotoxicants (Lash et al., 2002a 2002b; Xu et al., 2006).

Besides showing an increase in mitochondrial GSH content, we previously found markedly
increased rates of GSH uptake into renal mitochondria (Lash et al., 2001a). While this suggested
to us that expression of the DIC and/or the OGC might be up-regulated in compensatory renal
hypertrophy, measurements of both mRNA and protein expression for the two mitochondrial
carriers showed no differences between control and NPX rats. To understand, then, what is
responsible for the increased content of GSH in renal mitochondria from NPX rats, one has to
consider the functions of the DIC and OGC in dicarboxylate transport and the observations that
activities of several mitochondrial dehydrogenases and succinate-dependent respiration were
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significantly higher in renal mitochondria from NPX rats. The increased mitochondrial uptake of
GSH in compensatory renal hypertrophy, therefore, is likely due to kinetic or mass action effects
resulting from the hypermetabolic state. In other words, the higher supply of dicarboxylate
substrate for the two carriers drives the uptake of GSH into the mitochondria.
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Impact of compensatory hypertrophy on functional characteristics of renal mitochondria

Enzyme results
Activities of several enzymes that are indicative of cellular energetics and redox status were
measured in preparations of mitochondria and cytoplasm from renal cortex of control and NPX
rats (Table 4-3). With the exception of small decreases in mitochondrial GPX and cytoplasmic
GST in kidneys of NPX rats, there were no significant differences in activities of GSHdependent detoxification enzymes between control and NPX rat kidneys. In contrast, activities of
malic dehydrogenase, glutamate dehydrogenase and succinate: cytochrome c oxidoreductase
were significantly higher in renal mitochondria from NPX rats as compared to those from control
rats. These increases in key enzymes of mitochondrial intermediary metabolism without
corresponding changes in mitochondrial GSH-dependent enzymes are consistent with there being
changes in mitochondrial redox status in kidneys of NPX rats.
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Table 4-3. Effect of compensatory renal hypertrophy on GSH-dependent and
mitochondrial enzymes.
Enzyme activities were measured in cytoplasm or mitochondria isolated from kidney(s) of
uninephrectomized (NPX) rats at 10 days post-surgery and age-matched control rats. Results are
expressed as mU/mg protein and are means ± SEM of measurements from six rats from each
group.

Enzyme

Control

NPX

mU/mg protein

mU/mg protein

Mitochondria

16.5 ± 1.8

19.9 ± 0.9

Cytoplasm

21.1 ± 0.8

19.6 ± 0.8

Mitochondria

12.6 ± 0.5

9.69 ± 0.06*

Cytoplasm

11.7 ± 0.9

10.9 ± 0.8

Mitochondria

4.91 ± 0.97

2.71 ± 0.31*

Cytoplasm

34.1 ± 0.7

25.6 ± 0.2*

27.1 ± 1.7

38.3 ± 1.4*

57.7 ± 4.2

77.5 ± 6.1*

GSSG Reductase

GSH peroxidase

GSH S-transferase

Malic dehydrogenase
Mitochondria

Glutamate dehydrogenase
Mitochondria
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Succinate: cytochrome c oxidoreductase
Mitochondria

28.7 ± 1.1

56.7 ± 4.2*

*Significantly different (P < 0.05) from the corresponding value in control rats.
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Respiration results
Succinate-stimulated (complex II) state 3 respiration was also higher in renal mitochondria from
NPX rats than in those from control rats (Table 4-4). Similarly, the RCR value, which gives an
indication of how well oxygen consumption is coupled to ADP phosphorylation, was
significantly elevated with succinate (complex II) as respiratory substrate in renal mitochondria
from NPX rats relative to that in renal mitochondria from control rats. This significant
acceleration of mitochondrial respiratory activity after compensatory renal cellular hypertrophy
is consistent with the increased activities of mitochondrial dehydrogenases noted above and the
general hypothesis that renal mitochondria from NPX rats are in a hypermetabolic state.
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Table 4-4. Effects of compensatory renal hypertrophy on mitochondrial respiration.
Mitochondrial succinate-dependent State 3 and State 4 respiration were measured in suspensions
of isolated mitochondria from kidney(s) of control and NPX rats. Rates of oxygen consumption
were determined in an Oxygraph with a Clark-type electrode using 3.3 mM succinate as
respiratory substrate in the presence of 5 µM rotenone. Results are means ± SEM of
measurements from six separate mitochondrial preparations from each group.
RCR= respiratory control ratio = State 3 rate / State 4 rate.

Parameter

Control

NPX

State 4 (nmol O2/min per mg protein)

18.6 ± 1.4

19.7 ± 1.0

State 3 (nmol O2/min per mg protein)

27.0 ± 2.8

41.7 ± 1.5*

RCR

1.88 ± 0.02

3.16 ± 0.10*

*Significantly different (P<0.05) from the corresponding value in mitochondria from control
rats.
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Proteomics results
To further explore mitochondrial energetics data (enzyme activities and respiration), a
proteomics analysis of mitochondria from control and NPX rats was conducted to obtain an
overview of mitochondrial protein levels. Using the SEQUEST and X!Tandem search engines, a
total of 117 proteins were identified with ≥ 99% probability. Using the Mascot search engine, a
total of 72 proteins were identified with ≥ 95% probability, of which 25 proteins were
quantitated. For each protein, relative quantitation was calculated. As shown in Table 4-5, all the
numbers in bold print signify a 1.5-fold or higher difference.

In order to facilitate interpretation of mitochondrial proteomics data, we divided mitochondrial
proteins into different categories and defined proteins belonging to the respective categories. The
energy production category involves proteins that are involved in ATP synthesis and many
metabolic pathways such as the tricarboxylic acid cycle, electron transport chain, amino acid,
fatty acid, ketone body and drug metabolism. The apoptosis category is composed of proteins
known to play a role in mitochondrial stress response. The data show an increase in expression
of proteins that are involved in ATP synthesis, stress response, tricarboxylic acid (citric acid)
cycle, respiratory electron transport chain and various metabolic pathways including amino acid,
fatty acid and ketone body metabolism in the NPX group, further suggesting that a
hypermetabolic state exists after uninephrectomy and compensatory renal growth.
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Table 4-5. Mitochondrial Proteomics.
All the numbers in bold print signify a 1.5 fold or higher difference.
Relative quantitation: average signal intensity (NPX) / average signal intensity (Control)

Accession

NPX/Con
ATP Synthesis, Transport and Metabolic Processes

P10719

ATP synthase subunit beta

1.2

Q98QB6

ATP synthase subunit beta 2 (ATP synthase F1 sector subunit beta 2)

1.5

P15999

ATP synthase subunit alpha

1.5

P05141

ADP/ATP translocase 2 (ADP,ATP carrier protein 2)

0.8

Stress Response Proteins
Q64433

10 kDa heat shock protein (Hsp10)

1.4

P63038

Heat shock protein 60 (HSP-60)

1.7

Tricarboxylic acid cycle (Citrate Cycle)
P56574

Isocitrate dehydrogenase [NADP], (Oxalosuccinate decarboxylase)

1.6

Q9ER34

Aconitate hydratase, (Aconitase)

2.5

Respiratory Electron Transport Chain
Q52V09

Cytochrome c

1.4

P13803

Electron transfer flavoprotein subunit alpha

1.0
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Q66HF1

NADH-ubiquinone oxidoreductase 75 kDa subunit

1.9

Amino Acid and Fatty Acid Metabolic Pathways
P50442

Glycine amidinotransferase, (Transamidinase)

Q64565

Alanine-glyoxylate

aminotransferase

2,

1.9
(Beta-alanine-pyruvate 2.1

aminotransferase)
Q02253

Methylmalonate-semialdehyde

dehydrogenase

(Malonate- 1.3

semialdehyde dehydrogenase)
P08503

Medium-chain specific acyl-CoA dehydrogenase

Q64428

Trifunctional

enzyme

subunit

alpha,

2.6

(3-hydroxyacyl-CoA 0.7

dehydrogenase)
P26443

Glutamate dehydrogenase 1

1.9

Ketone Metabolism
Q9D0K2

Succinyl-CoA:3-ketoacid-coenzyme A transferase 1, (3-oxoacid 1.5
CoA-transferase 1)
Drug Metabolism

Q64573

Kidney microsomal carboxylesterase (Liver carboxylesterase 3)

1.5

Anion Transport (Transmembrane Transport)
Q9Z2L0

Voltage-dependent anion-selective channel protein 1 (VDAC-1)
Amino acid Transport

1.1
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Q64319

Neutral and basic amino acid transport protein rBAT (B(0,+)-type 1.0
amino acid transport protein)
Oxidoreductase Activity

Q6AYT0

Quinone oxidoreductase (Zeta-crystallin)

1.2

Q07523

Hydroxyacid oxidase 2

1.0

Q68FT3

Probable oxidoreductase C10orf33 homolog

1.9

Q9DBF1

Aldehyde dehydrogenase family 7 member A1 (Antiquitin-1)

0.9
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Discussion
The basic concept of the hypermetabolic state that is suggested to exist in compensatory renal
hypertrophy is that the remnant renal tissue must work harder to try and make up for the lost
function. The principal means to accomplish this is through increased generation of ATP by the
mitochondria, which is tightly regulated in the kidneys according to the need for metabolic
energy (Soltoff, 1986). In the present study, evidence for increased rates of mitochondrial
metabolism were the significant increases in activities of malic, glutamate, and succinate
dehydrogenases and State 3 rates of succinate-dependent respiration. We also observed
significantly higher protein expression of the (Na++K+)-ATPase in kidneys from NPX rats,
which agrees with our previous observation of higher enzymatic activity in renal PT cells from
NPX rats (Lash et al., 2001b). Because this protein is one of the primary consumers of ATP in
the renal PT cell (Soltoff, 1986), its higher expression and activity in kidneys from NPX rats as
compared to those from control rats provide further support for the conclusion that compensatory
renal hypertrophy generates a hypermetabolic state in the remnant renal cell due to increased
energy demands.

In this study, we applied proteomics for relative quantification of mitochondrial proteins and
analyzed the main pathways of mitochondrial activity for energy metabolism and stress response.
Consistent with mitochondrial enzyme and respiration data, mitochondrial proteomics data also
suggest the existence of a hypermetabolic state and stress in mitochondria from hypertrophied
kidney. As mitochondrial proteins are central to various metabolic activities, disturbance of
mitochondrial proteins is also often associated with a variety of diseases or various pathological
states such as respiratory chain defects, fatty acid oxidation deficiencies and neurodegenerative
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disease (Chan, 2006; Janssen et al., 2004; Gregersen et al, 2004; Kwong et al., 2006). This
assessment of mitochondrial proteins provides specific, mechanistic information about molecular
changes that influence cellular metabolism in mitochondria from both hypertrophied and normal
kidney.

Overall, our enzyme, respiration and proteomics data suggested a hypermetabolic state in
hypertrophied kidney. As mitochondria are the major organelles to produce superoxide anion in
cells, increased mitochondrial respiration and mitochondrial function also suggests potential
increase in reactive oxygen species (ROS) formation, which in turn possibly lead to a higher
basal state of oxidant stress as compared to mitochondria from normal rat kidneys. In addition,
the upregulation of mitochondrial proteins that are involved in metabolic pathways and apoptosis
might be a way for cells to cope with potential basal oxidative stress during compensatory renal
hypertrophy.
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Assessment of basal and toxicant-induced oxidative stress in renal mitochondria

Results
The hypermetabolic state of renal mitochondria from NPX rats, and the evidence of renal
dysfunction, suggest that a higher state of oxidative stress exists that may contribute to higher
susceptibility to chemically induced injury. To compare basal and toxicant induced oxidative
stress between renal mitochondria from control and NPX rats, we analyzed lipid peroxidation by
using two assays (one assay based on MDA formation and one based on degradation of cisparinaric acid) and measured aconitase activity as a marker for mitochondrial oxidative stress.
We also examined two types of protein adducts as oxidative stress markers, 3-NT (3nitrotyrosine) and HNE (4-hydroxy-2-nonenal).

The results of the MDA assay show that there is no significant difference in renal mitochondrial
lipid peroxidation between control and NPX rats under either basal conditions or when
mitochondria are challenged by exposure to tBH (Figure 4-3A). The naturally occurring
polyunsaturated fatty acid cis-parinaric acid is used in eukaryotic cells as a very sensitive marker
for the initial stages of lipid peroxidation (Tribble et al., 1994). When double bonds of cisparinaric acid are broken in lipid peroxidation reactions, decay in fluorescence is used to
indirectly monitor the degree of membrane lipid peroxidation. Under anaerobic conditions (N 2 +
Fe2+), there was no significant difference in either basal or tBH-induced mitochondrial lipid
peroxidation between control and NPX rats (Figure 4-3B).
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Because mitochondrial aconitase activity is a sensitive indicator of redox homeostasis and its
activity is uniquely sensitive to various physiological and pathological conditions (James et al.,
2002), it is frequently viewed as a marker of oxidative stress in biological systems. The
underlying mechanism is believed to be the facile inactivation of its iron–sulfur prosthetic group
by toxicants such as peroxides (Han et al., 2003; James et al., 2002; Gardner et al., 1994). As
shown in Figure 4-3C, renal aconitase activity was significantly lower in mitochondria from
NPX rats relative to control rats even without any exogenous toxicant, suggesting that renal
compensatory hypertrophy does cause an increase in underlying mitochondrial oxidative stress.
The progressive oxidative stress in animals with renal insufficiency can lead to oxidation of
proteins, carbohydrates, nucleic acids, lipids and accumulation of harmful byproducts in various
tissues (Himmelfarb et al., 2002; Vaziri, 2004). As a further assessment of mitochondrial redox
status, we analyzed protein adducts of two oxidative stress markers, 3-NT and HNE, by Western
blot analysis in renal mitochondria. No differences were observed in blots for 3-NT modified
proteins (data not shown). However, assessment of HNE-adducted proteins showed significantly
higher staining in renal mitochondria from NPX rats, with the most prominent staining at 45 kDa
and 52 kDa (Figure 4-3D).

To analyze the effect of toxicant (tBH) on mitochondrial protein levels, we performed proteomic
analyses on mitochondrial samples from control and NPX groups. Using the Mascot search
engine, a total of 72 proteins were identified with ≥ 95% probability, of which 25 proteins were
quantitated. For each protein, relative quantitation was calculated. As shown in Table 4-6, all the
numbers in bold print signify a 1.5-fold or higher difference and a 0.5-fold or lower difference.
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The comparison of NPX-tBH/Control-tBH protein expression cannot clearly suggest if changes
are due to the effects of nephrectomy or toxicant-treatment. To further explore these data, we
also analyzed the protein fold change using NPX-tBH/NPX and Control-tBH/Control
comparisons. The data show that tBH treatment caused a significant decrease in expression of
proteins in mitochondria from both control (Control-tBH/Control) and NPX (NPX-tBH/NPX)
groups. This lower protein expression may be a result of cellular toxicity due to too high a
concentration of or exposure time to tBH. In addition, tBH treatment had similar effects on
mitochondrial proteins from both control and NPX groups that are involved in the citric acid
cycle, electron transport chain, amino acid, fatty acid, ketone and drug metabolism.
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Figure 4-3. Assessment of effects of compensatory renal growth on basal and toxicantinduced oxidative stress in renal mitochondria.
A. Basal and tBH-induced lipid peroxidation in renal mitochondria from CON and NPX rats was
measured using malondialdehyde (MDA) formation, as determined with 1-methyl-2phenylindole. Renal mitochondrial samples from CON and NPX rats were incubated with buffer
or 500 µM tBH for 1h. Results are means ± SEM of three separate samples from each group.
*Significantly different (P < 0.05) from the corresponding untreated samples.
B. Basal and tert-butyl hydroperoxide (tBH)-induced lipid peroxidation in renal mitochondria
from control (CON) and uninephrectomized (NPX) rats was measured using fluorescent cisparinaric acid. Renal mitochondrial samples were incubated with 6.4 mM cis-parinaric acid + 5
mM hemin and treated with either 200 µM or 500 µM tBH. Results are means ± SEM of three
separate samples from each group. *Significantly different (P < 0.05) from the corresponding
untreated samples.
C. Mitochondrial aconitase activity in renal mitochondria from CON and NPX rats was
measured as NADPH formation at A340. Results are means ± SEM of three separate samples
from each group. *Significantly different (P < 0.05) from the value in mitochondria from CON
rats.
D. Adducts of 4-hydroxy-2-nonenal (HNE) with mitochondrial proteins were determined by
Western blot analysis. VDAC protein was used as a mitochondrial loading control. Blots were
quantified by densitometry using GelEval 1.22 software. Data are presented as means ± SEM of
three separate samples from each group. *Significantly different (P < 0.05) compared to
corresponding sample from CON rats.
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Table 4-6. Effect of toxicant (tBH) on mitochondrial protein expression during compensatory renal hypertrophy.
All the numbers in bold print signify a 1.5-fold or higher difference and a 0.5-fold or lower difference.
Relative quantitation: average signal intensity (NPX-tBH) / average signal intensity (NPX)
average signal intensity (Control-tBH) / average signal intensity (Control)
average signal intensity (NPX-tBH) / average signal intensity (Control-tBH)

Accession

Control-tBH/

NPX-tBH/

NPX

Control

Control-tBH

0.9

0.6

1.5

1.2

0.5

3.2

ATP Synthesis, Transport and Metabolic
Processes
P10719

ATP synthase subunit beta

Q98QB6

ATP synthase subunit beta 2 (ATP synthase F1
sector subunit beta 2)
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NPX-tBH/

P15999

ATP synthase subunit alpha

P05141

ADP/ATP translocase 2 (ADP,ATP carrier

0.8

0.8

1.3

0.7

0.4

1.4

0.7

0.4

2.4

0.9

0.5

1.6

0.7

0.6

1.2

0.6

0.7

1.1

protein 2)
Stress Response Proteins
Q64433

10 kDa heat shock protein (Hsp10)

P63038

Heat shock protein 60 (HSP-60)
Tricarboxylic acid cycle (Citrate Cycle)
Isocitrate

dehydrogenase

[NADP],

(Oxalosuccinate decarboxylase)
Q9ER34

Aconitate hydratase, (Aconitase)
Respiratory Electron Transport Chain

Q52V09

Cytochrome c

0.5

0.3

2.3

Q66HF1

NADH-ubiquinone oxidoreductase 75 kDa 0.2

0.1

0.4

subunit
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P56574

Amino Acid and Fatty Acid Metabolic
Pathways
P50442

Glycine amidinotransferase, (Transamidinase)

1.1

1.2

1.4

Q64565

Alanine-glyoxylate aminotransferase 2, (Beta- 0.5

0.6

1.1

0.7

0.5

1.8

0.7

1.5

1.2

(3- 0.5

0.5

1.0

0.5

0.6

1.4

mitochondrial 3.6

4.8

0.6

alanine-pyruvate aminotransferase)
Q02253

Methylmalonate-semialdehyde dehydrogenase
(Malonate-semialdehyde dehydrogenase)
Medium-chain

specific

acyl-CoA

dehydrogenase
Q64428

Trifunctional

enzyme

subunit

alpha,

hydroxyacyl-CoA dehydrogenase)
P26443

Glutamate dehydrogenase 1

P00507

Aspartate

aminotransferase,

precursor (Transaminase A)
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P08503

Ketone Metabolism
Q9D0K2

A 0.5

0.6

0.9

Kidney microsomal carboxylesterase (Liver 0.3

0.4

1.5

1.2

0.6

1.9

0.6

0.5

1.2

Succinyl-CoA:3-ketoacid-coenzyme
transferase 1, (3-oxoacid CoA-transferase 1)
Drug Metabolism

Q64573

carboxylesterase 3)
Anion

Transport

(Transmembrane
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Transport)
Q9Z2L0

Voltage-dependent

anion-selective

channel

protein 1 (VDAC-1)
Amino acid Transport
Q64319

Neutral and basic amino acid transport protein
rBAT
protein)

(B(0,+)-type

amino

acid

transport

Oxidoreductase Activity
Q6AYT0

Quinone oxidoreductase (Zeta-crystallin)

Q07523

Hydroxyacid oxidase 2

Q68FT3

Probable oxidoreductase C10orf33 homolog

Q9DBF1

Aldehyde dehydrogenase family 7 member A1

0.8

0.9

1.1

0.6

0.5

1.3

0.3

1.0

0.7

1.7

0.6

4.6

(Antiquitin-1)
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Discussion
Inasmuch as the mitochondria are the principal intracellular sites of oxygen consumption and
increased rates of electron transport are believed to be associated with increased release of
reactive oxygen species, we hypothesized that the consequence of these changes in
mitochondrial function is an enhancement of basal oxidant stress (Lash et al., 2001a). The
current studies pursued this further by assessing both basal and toxicant-stimulated lipid
peroxidation using two well-established assays, formation of MDA and degradation of cisparinaric acid. We also measured activity of mitochondrial aconitase, which, as noted above, is
considered a highly sensitive indicator of oxidative stress due to the facile oxidation of its Fe-S
cluster leading to inactivation (Han et al., 2003; James et al., 2002; Gardner et al., 1994).

Neither assessment of lipid peroxidation showed a significant difference between control and
NPX kidneys, either in the absence or presence of toxicant. Expression of two important redox
proteins in renal mitochondria, SOD2 and Trx2, were also unchanged after compensatory renal
hypertrophy. An important consideration in evaluating such data, however, is the manner by
which the measurements are normalized. In the present work, enzyme activities and levels of
metabolites were normalized to total protein content, which was the only normalization
parameter available and is the one that is most commonly used. Part of the compensatory
hypertrophy response, however, is an increase in protein per cell (Meyer et al., 1996; Fine, 1986;
Shirley and Walter, 1991; Wolf and Neilson, 1991). We previously illustrated the impact of this
by normalizing activities in renal PT cell primary cultures derived from either control or NPX
rats to both protein and DNA content (Lash et al., 2001b). Whereas the amount of total protein

94

per cell increases as a consequence of compensatory renal hypertrophy, the amount of DNA per
cell does not change owing to the absence of a significant hyperplasia after a reduction in renal
mass. Thus, lack of a difference between samples from control and NPX rats when normalized to
protein equates to an increase, although one that is proportional to protein.

In contrast to the lipid peroxidation data, the mitochondrial aconitase activity data showed
significant redox imbalance, suggesting an increase in mitochondrial oxidative stress in NPX
kidney. To further support the conclusion that there is a degree of redox imbalance in renal
mitochondria of NPX rats, we observed a significant increase in the amount of HNE-modified
protein. The increase in Western blot density was 1.7-fold and was predominantly detected in
two protein bands of molecular weight 52 kDa and 45 kDa. Although the identity of these
modified proteins is currently unknown, their detection and the extent of the difference between
renal mitochondria from control and NPX rats, suggest they may be important in determining the
compensatory hypertrophy phenotype. Potential nitration of mitochondrial proteins was also
assessed, but no difference between renal mitochondria from control and NPX rats was found,
suggesting that increases in reactive nitrogen species were not a component of the compensatory
hypertrophy phenotype.

The relative quantitation of proteins from mitochondrial pathways enabled the detection of
toxicant-induced changes in mitochondria from hypertrophied kidney, suggesting alterations in
susceptibility to mitochondrial toxicants. Overall, the proteomic analysis identified a number of
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toxicant-induced changes during compensatory renal hypertrophy that could be involved in
mediating mitochondrial toxicant-induced oxidative stress. Further exploration of these changes
may provide insight into whether or not mitochondrial toxicant-induced stress response in
hypertrophied kidney is due to cell death or any other mechanism. From our data, it is not clear if
the similar effect of the toxicant, tBH, on mitochondrial proteins from both control and NPX
groups is due to use of too high a concentration of tBH or too long an exposure. It would be
interesting to treat the mitochondria with multiple concentrations of toxicants in multiple
mitochondrial samples from control and NPX groups.
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Effect of compensatory renal hypertrophy on mitochondrial size, number and membrane
potential

Results
Effect of compensatory renal hypertrophy on mitochondrial size and number in renal PT
cells
Based on contradictory data from previous studies (Cuppage et al., 1973; Hwang et al., 1990),
our goal was to study basic properties of renal mitochondria after compensatory renal
hypertrophy due to uninephrectomy. To label mitochondria, PT cells were incubated with
MitoTrackerTM probes, which passively pass across plasma membranes and accumulate in
metabolically active mitochondria. Our data showed a significant increase in mitochondrial
staining with MitoTrackerTM dye in NPX rats, suggesting a possibility of either an increase in
mitochondrial number (proliferation) or size (hypertrophy). To further explore these data,
mitochondrial DNA and mitochondrial protein were measured. As shown in Figure 4-5 and
Figure 4-6, the data indicate no significant difference in mitochondrial DNA but significant
increases in mitochondrial protein contents in the NPX group, suggesting renal mitochondrial
hypertrophy in the NPX group.
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Renal PT cells from NPX rats have higher basal mitochondrial membrane potential than
those from control rats
To analyze mitochondrial membrane potential, PT cells were incubated with JC-1 (Figure 4-4).
JC-1 is a cationic dye that exhibits membrane potential-dependent accumulation in mitochondria,
indicated by shifting its fluorescence emission from green (~525 nm) to red (~590 nm). Polarized
mitochondria are indicated by punctate red staining. The graphs represent average quantitation of
three images and show a marked increase in JC-1 red punctate staining and no significant
difference in JC-1 green staining. Overall, these data demonstrate an increase in JC-1 red
punctate staining in kidneys of NPX rats, which is higher than the increase in MitoTracker TM
staining, suggesting a hyperpolarized state in the kidneys of NPX rats.
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Figure 4-4. MitoTrackerTM staining.
PT cells were grown on 35 mm dishes for 4 days and incubated with MitoTracker TM (50 nM) for
30 min. MitoTrackerTM staining in PT cells from Control and NPX rats was measured using a
Zeiss LSM 510 confocal microscope.
A) Images of MitoTrackerTM staining were measured by confocal microscopy at 554 nm
excitation and 576 nm emission. Magnification = 630x.
B) The graph represents average quantitation of three images. The integrated intensity of the
entire image was done using Metamorph 7.1.7.0 Offline. *Significantly different (P < 0.05) from
control cells.
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A.

B.
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Figure 4-5. Mitochondrial DNA.
Mitochondrial DNA was measured by DNA fluorescence assay. DAPI fluorescence was
measured at 360 nm excitation and 450 nm emission. Results are means ± SEM of three separate
samples from each group.
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Figure 4-6. Mitochondrial protein.
Mitochondrial protein contents were measured by the BCA protein assay. *Significantly
different (P < 0.05). Data are presented as means ± SEM of three separate samples from each
group.
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Figure 4-7. Measurement of mitochondrial membrane potential in PT cells from control
and NPX rats.
PT cells were incubated with JC-1 (5 µg/ml) for 30 min. JC-1 fluorescence was measured by
confocal microscopy using an overlay of red (488 nm excitation, 590 nm emission) and green
(488 nm excitation, 525 nm emission) on a Zeiss LSM 510 confocal microscope.
A) JC-1 aggregate is indicated by red punctate staining (left panel). JC-1 monomer is indicated
by green staining (middle panel). The overlay of both images is indicated by yellow color, which
indicates co-localization of red and green (right panel). Magnification = 630x
B) The graphs represent average quantitation of three images. The integrated intensity of the
entire image was measured by using Metamorph 7.1.7.0 Offline. *Significantly different (P <
0.05) from control cells.
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Discussion
In contrast to previous studies that suggested the existence of both renal mitochondrial
proliferation and hypertrophy (Johnson and Amendola, 1969; Cuppage et al., 1973), Hwang‟s
group (Hwang et al., 1990) concluded only mitochondrial hypertrophy of a fixed number of
mitochondria in compensatory renal hypertrophy of renal PT cells. On the basis of these previous
studies, which have suggested renal mitochondrial proliferation and hypertrophy, we analyzed
properties of renal mitochondria after compensatory renal hypertrophy due to uninephrectomy.
In the present study, we demonstrated the occurrence of renal mitochondrial hypertrophy
following reduction in renal mass that was presumably to satisfy the greater need for energy
metabolism (Benipal and Lash, 2011). This is consistent with data from the studies of Hwang
and colleagues (Hwang et al., 1990).

The elevation in basal mitochondrial membrane potential suggested the existence of a
hyperpolarized state, which is consistent with our previous data of higher rates of state 3
respiration in isolated renal mitochondria from NPX rats (Benipal and Lash, 2011). These data
suggest that increased rates of electron flow and hyperpolarization by increased mitochondrial
respiration further lead to increased reactive oxygen species formation, which potentially causes
a significant degree of redox imbalance and basal oxidative stress in renal mitochondria, as
suggested by our recent studies (Benipal and Lash, 2011), and increased susceptibility of PT
cells from NPX rats to nephrotoxicants (Lash et al., 2006).
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CHAPTER V. MODULATION OF MITOCHONDRIAL REDOX STATUS IN PT
CELLS TO REDUCE THE RISK OF SUSCEPTIBILTY TO NEPHROTOXICANTS.

Influence of overexpression of the DIC on susceptibility to chemically induced toxicity by
mitochondrial toxicants

Results
The overexpression of the DIC was confirmed by analyzing gene expression. As shown in Table
5-1, overexpression of DIC plasmids leads to a 7,806-fold increase in DIC gene expression.
Acute cytotoxicity was assessed by measuring lactate dehydrogenase (LDH) release in renal PT
cells from NPX rats. After transfection with the DIC plasmid, the PT cells were treated with
either AA (1 µM, 10 µM), tBH (100 µM, 200 µM) or MVK (100 µM, 200 µM) without or with
an overnight supplementation with 5 mM GSH. With endogenous GSH, overexpression of DIC
did not cause any significant change in LDH release induced by AA (Figure 5-1A). However,
after supplementation of PT cells with GSH, overexpression of DIC caused protection against the
mitochondrial specific toxicant AA (Figure 5-1B). Furthermore, overexpression of DIC did not
cause any protection against tBH or MVK with endogenous or supplemented GSH in PT cells
from NPX rats (Figure 5-1A and Figure 5-1B).
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Table 5-1. Analysis of DIC gene overexpression by RT-PCR in renal proximal tubular cells
from NPX rats.
Primers for the DIC were designed with the aid of Oligo 6.76 and the cDNA sequences
published in GenBank

TM

. An optimum cDNA concentration of 30–300 ng DNA/well was

determined for each gene. All CT values are based on triplicate measurements from total RNA
from 3 renal PT cell preparations from NPX rats and are means ± SEM. GAPDH CT values were
used for correction: For control and DIC-transfected samples, GAPDH CT values = 27.8 ± 0.2
for control and 31.7 ± 0.5 for DIC-transfected. Relative gene expression values were calculated
by the formula: 2-∆CT (DIC-transfected) / 2-∆CT (Control), ∆CT value is the difference between the CT value
for the gene of interest and that of GAPDH.

Control

DIC-transfected

CT mean ± SE

CT mean ± SE

30.3 ± 0.1

21.3 ± 0.2

Relative Expression
(DIC-transfected / Control)
7,806
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Figure 5-1. Effect of overexpression of the DIC on sensitivity to chemical-induced toxicity.
A. Experiments were performed on day 6 of cell culture (72 h post-DIC transfection).
Suspensions of PT cells isolated from NPX rats were treated with the indicated concentrations of
AA, MVK or tBH for 4 h. After 4 h, aliquots were removed and LDH activity was measured.
Values represent means ± SEM. Data shown here are the average of three experiments.
B. Experiments were performed on day 6 of cell culture (72 h post-DIC transfection).
Suspensions of PT cells isolated from NPX rats were incubated with 5 mM GSH overnight prior
to treatment with the indicated concentrations of AA, MVK or tBH for 4 h. After 4 h, aliquots
were removed and LDH activity was measured. Values represent means ± SEM. Data shown
here are the average of three experiments. *Significantly different (P < 0.05).
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Influence of overexpression of the OGC on susceptibility to chemically induced toxicity by
mitochondrial toxicants

Results
Overexpression of the OGC was confirmed by analyzing gene expression. As shown in Table 52, overexpression of OGC plasmids lead to a 5,007-fold increase in OGC gene expression. Acute
cytotoxicity was assessed by measuring LDH release in PT cells from NPX rats. After
transfection with the OGC plasmid, the PT cells were treated with either AA (1 µM, 10 µM),
tBH (100 µM, 200 µM) or MVK (100 µM, 200 µM) without or with an overnight
supplementation with 5 mM GSH. With endogenous GSH, overexpression of OGC did not cause
any significant change in LDH release induced by AA (Figure 5-2A). However, after
supplementation of PT cells with GSH, overexpression of OGC caused protection against the
mitochondrial specific toxicant AA (Figure 5-2B). Furthermore, overexpression of OGC did not
cause any protection against tBH or MVK with either endogenous or supplemented GSH
(Figure 5-2A and Figure 5-2B) in PT cells from NPX rats.

Overall, these results suggest higher GSH transport activity by overexpression of DIC and OGC
in renal PT cells of hypertrophied kidney markedly protected against toxicity and oxidative stress
induced by the mitochondrial selective toxicant AA, indicating the significance of mitochondrial
GSH transport in determining susceptibility to cytotoxic chemicals.
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Table 5-2. Analysis of OGC gene overexpression by RT-PCR in renal proximal tubule cells
of NPX rats.
Primers for the OGC were designed with the aid of Oligo 6.76 and the cDNA sequences
published in GenBank

TM

. An optimum cDNA concentration of 30 to 300 ng DNA/well was

determined for each gene. All CT values are based on triplicate measurements from total RNA
from 3 renal PT cell preparations from NPX rats and are means ± SEM. GAPDH CT values were
used for correction: For control and OGC-transfected samples, GAPDH CT values = 27.8 ± 0.1
for control and 28.3 ± 0.2 for OGC-transfected. Relative gene expression values were calculated
by the formula: 2 -∆CT

(OGC-transfected)

/ 2-∆CT

(Control)

, ∆CT value is the difference between the CT

value for the gene of interest and that of GAPDH.

Control

OGC-transfected

CT mean ± SE

CT mean ± SE

31.8 ± 0.3

20.0 ± 0.5

Relative Expression
(OGC-transfected / Control)
5,007
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Figure 5-2. Effect of overexpression of the OGC on sensitivity to chemical-induced toxicity.
A. Experiments were performed on day 6 of cell culture (72 h post-OGC transfection).
Suspensions of PT cells isolated from NPX rats were treated with the indicated concentrations of
AA, MVK or tBH for 4 h. After 4 h, aliquots were removed and LDH activity was measured.
Values represent means ± SEM. Data shown here are the average of three experiments.
B. Experiments were performed on day 6 of cell culture (72 h post-OGC transfection).
Suspensions of PT cells isolated from NPX rats were incubated with 5mM GSH overnight prior
to treatment with the indicated concentrations of AA, MVK or tBH for 4 h. After 4 h, aliquots
were removed and LDH activity was measured. Values represent means ± SEM. Data shown
here are the average of three experiments. *Significantly different (P < 0.05).
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Figure 5-2B.
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Discussion
Our previous reports showed a significant degree of redox imbalance and basal oxidative stress
in renal mitochondria (Benipal and Lash, 2011) and an increased susceptibility of PT cells from
NPX rats to nephrotoxicants (Lash et al., 2006). Furthermore, our lab also showed in NRK-52E
cells that overexpression of mitochondrial GSH transporters protected against nephrotoxicants
(Lash et al., 2002b; Xu et al., 2006). Taken together, these observations suggested that a
threshold level of mitochondrial GSH is needed to counteract oxidative stress and susceptibility
to toxicants in PT cells. Thus, we hypothesized that further increases in mitochondrial GSH
levels in PT cells by overexpression of DIC and/or OGC will improve mitochondrial energetics
and redox status and lower susceptibility to mitochondrial toxicants.

In this study, our approach was to increase GSH content in a subcellular organelle, mitochondria,
by altering expression of the DIC and OGC to effect desired changes in mitochondrial GSH
status. To investigate the toxicological consequences of altering mitochondrial GSH transport,
we incubated renal PT cells from NPX rats with three mechanistically distinct mitochondrial
toxicants, AA, tBH, and MVK. All three toxicants are unique in their mechanisms as shown in
Figure 5-3. AA is a specific mitochondrial inhibitor that decreases mitochondrial electron
transport chain activity and mitochondrial membrane potential leading to increases in reactive
oxygen species. tBH is an oxidant that causes lipid peroxidation and GSH oxidation whereas
MVK is an alkylating agent that causes GSH depletion by formation of GSH adducts.

Interestingly, assessment of cytotoxicity by LDH release demonstrated that overexpression of
either of the mitochondrial GSH carriers, the DIC and OGC, only protected against AA. This
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extensive protection against AA by overexpression of mitochondrial GSH transporters can be
explained by a direct effect of AA on the mitochondrial electron transport chain. In other words,
out of all three toxicants, AA specifically inhibits mitochondria and consequently, increased
mitochondrial GSH by overexpression of GSH transporters decreases the oxidative stress
induced by AA. Thus, consistent with our previous data in NRK-52E cells (Lash et al., 2002b;
Xu et al., 2006), our present data also demonstrated that manipulation of mitochondria by
overexpression of mitochondrial GSH carriers, DIC and OGC, reduced the risk of susceptibility
to nephrotoxicants in hypertrophied kidney cells.

Overall, our data represent a significant analysis of the influence of modulation of renal
mitochondrial GSH transport on the influence of compensatory renal hypertrophy on
susceptibility of renal PT cells to mitochondrial toxicants. Furthermore, it would be interesting to
extend this study by analyzing the effect of overexpression of the mitochondrial GSH
transporters, DIC and OGC, on oxidative stress, proliferation and cellular GSH status. The
ultimate goal of this study is to improve renal redox status after reduction in kidney mass by
increasing mitochondrial GSH. This is then intended to reduce the risk of susceptibility to
nephrotoxicants as reported by our previous studies (Lash et al., 2006; Lash et al., 2002b; Xu et
al., 2006). Besides compensatory renal hypertrophy after reduction in kidney mass, GSH
dysregulation is also associated with a number of toxic and pathological states. For example,
lower cellular GSH levels are associated with diabetes, neurodegeneration and cardiovascular
diseases (Ballatori et al., 2009) and depletion or oxidation of mitochondrial GSH is associated
with cirrhosis, diabetic nephropathy and alcoholic liver disease (Fernandez-Checa et al., 1993;
Krahenbuhl et al., 1992; Santos et al., 2003; Mastrocola et al., 2005). Towards this end, our
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approach of improving cellular and subcellular (mitochondrial) GSH status might be applicable
to not only compensatory renal hypertrophy but also to diseases that are associated with GSH
dysregulation.
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Figure 5-3. Mitochondrial toxicants.

A) Antimycin A

B) tert-butyl hydroperoxide

C) Methyl vinyl ketone
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CHAPTER VI. SUMMARY AND CONCLUSIONS
The primary goal of this dissertation was to further characterize renal function and mitochondrial
status during compensatory renal hypertrophy caused by uninephrectomy and to further expand
on our previous studies of modulating renal mitochondrial redox status. We hypothesize that
compensatory renal hypertrophy after uninephrectomy alters renal function and mitochondrial
status and modulation of mitochondrial redox status alters susceptibility to nephrotoxicants in
hypertrophied kidney cells. To study compensatory renal hypertrophy, we used the
uninephrectomy rat model as this model has been reasonably well characterized as to the
physiological and morphological changes that occur.

The analysis of renal physiological parameters suggested that the compensatory response of the
remaining kidney after uninephrectomy is associated with modest impairment of renal function
as assessed by blood and urinary parameters. The previous observations suggested that
compensatory renal hypertrophy is associated with a significant increase in GSH content by
higher activity of -glutamylcysteine synthetase (GCS). To further explore another potential
mechanism for the increase in the cytoplasmic pool of GSH, we analyzed the expression of
several plasma membrane carrier proteins that are responsible for GSH transport into PT cells to
determine whether or not there is increased transport of GSH across the BLM. Our results
showed significantly higher protein expression of Oat1 and Oat3, which play a role in GSH
uptake, and higher protein expression of the (Na ++K+)-stimulated ATPase, which provides the
Na+ ion gradient for secondary active transporters that ultimately help mediate the uptake of
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GSH. Overall, these results suggested that higher intracellular accumulation of GSH is due to
higher activity of GCS and increased GSH transport across the BLM.

After analyzing renal plasma membrane GSH transporters, the next goal was to see whether or
not compensatory renal hypertrophy caused alterations in renal mitochondrial redox status,
including GSH and the redox enzymes superoxide dismutase (Sod2) and thioredoxin2 (Trx2).
The analysis of renal mitochondrial glutathione status showed modest but significant increases in
both GSH and GSSG in renal mitochondria from NPX rats as compared to control rats. We next
determined gene and protein expression of two inner mitochondrial carrier proteins, the DIC and
OGC, which partially determine renal mitochondrial GSH status. In contrast to our expectations,
neither gene nor protein expression of the DIC or OGC were increased and there were no
changes in protein expression of the mitochondrial redox enzymes Sod2 and Trx2 after
uninephrectomy. Hence, we concluded that the increase in mitochondrial GSH concentrations is
due to mass action or changes in the kinetics of the mitochondrial GSH transporters, DIC and
OGC, caused by a hypermetabolic state.

To analyze the impact of compensatory renal hypertrophy on functional characteristics of renal
mitochondria, we analyzed activities of mitochondrial enzymes that are indicative of cellular
energetics and redox status. To further explore mitochondrial energetics, we also looked at
mitochondrial respiration and proteomics. All the results provided evidence for a hypermetabolic
state in the NPX group signified by increases in activities of energetics enzymes, state 3 rates of
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respiration and expression of proteins that are involved in various metabolic pathways. Overall,
these observations suggest that to accommodate the increased energy demand caused by
compensatory renal hypertrophy, there are increased rates of mitochondrial electron transport
chain leading to the hypermetabolic state that can also lead to mitochondrial dysfunction due to
increased ROS formation.

The evidence for renal dysfunction and a hypermetabolic state of renal mitochondria from NPX
rats suggested that a higher state of mitochondrial oxidative stress exists that may also contribute
to higher susceptibility to chemically induced renal injury. Hence, our next goal was to compare
basal and toxicant-induced renal mitochondrial oxidative stress between control and NPX rats.
We analyzed both basal and toxicant-stimulated lipid peroxidation and aconitase activity, which
is a highly sensitive indicator of oxidative stress in biological systems. The assessment of basal
and toxicant-induced lipid peroxidation data showed no significant difference between control
and NPX kidneys. However, aconitase activity data suggested redox imbalance leading to
increased mitochondrial oxidative stress, which is further supported by significant increases in
the amount of HNE-adducted proteins in renal mitochondria from NPX rats.

Based on previous observations that were contradictory and suggested both renal mitochondrial
proliferation and hypertrophy on the one hand and only mitochondrial hypertrophy on the other
hand, our goal was to further explore the effect of compensatory renal hypertrophy on
mitochondrial size and number in renal PT cells. We showed that mitochondrial hypertrophy of

122

renal PT cells follows reduction in renal mass to satisfy the need for energy metabolism during
compensatory renal hypertrophy. Furthermore, elevation in basal membrane potential as shown
by JC-1 staining suggested a hyperpolarized state in mitochondria from the NPX group. This
suggested that hyperpolarization caused by increased mitochondrial respiration further leads to
basal mitochondrial oxidative stress and increased susceptibility of PT cells to nephrotoxicants in
the NPX group.

Finally, to test our hypothesis that increasing renal mitochondrial GSH reduces the risk of
susceptibility to nephrotoxicants in hypertrophied kidney cells, we overexpressed two
mitochondrial GSH carriers, the DIC and OGC, in PT cells from the NPX group. The basic idea
was that overexpression of mitochondrial GSH transporters would decrease susceptibility to
nephrotoxicants by increasing mitochondrial GSH levels caused by increased expression and
transport activity of GSH transporters, the DIC and OGC. The assessment of cytotoxicity
showed that after supplementation of PT cells with GSH, overexpression of mitochondrial GSH
transporters protected against the mitochondrial specific toxicant antimycin A. These data
supported our hypothesis that higher mitochondrial GSH transport activity by overexpression of
the DIC and OGC in hypertrophied kidney cells markedly protected against toxicity, supporting
the significance of mitochondrial GSH transport in determining susceptibility to toxicants.

In summary, we showed that in hypertrophied kidney there are alterations in physiological
parameters suggesting modest renal dysfunction, higher expression of renal organic anion
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transporters suggesting higher transport of GSH and higher transport of xenobiotics leading to an
increase in susceptibility to nephrotoxicants, and alterations in hypertrophied mitochondria
suggesting redox imbalance and increased basal oxidative stress. As shown in Figure 6-1, we
conclude that in hypertrophied mitochondria, a hypermetabolic state caused by increases in citric
acid cycle and electron transport chain activities lead to a hyperpolarized state and superoxide
production, which further causes mitochondrial oxidative stress. Furthermore, the increase in
mitochondrial GSH concentrations is due to mass action or a kinetic effect on mitochondrial
GSH transporters. In addition, our data also provide evidence that manipulation of mitochondrial
GSH transport modulates response to nephrotoxicants, supporting the toxicological significance
of the mitochondrial GSH transport process in compensatory renal hypertrophy.
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Figure 6-1. Summary scheme.
Abbreviations: DIC, dicarboxylate carrier; ROS, reactive oxygen species; O 2 -, superoxide anion;
OGC, oxoglutarate carrier; 2-OG2–, 2-oxoglutarate; Pi2-, inorganic phosphate; TCA, tricarboxylic
acid cycle.
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CHAPTER VII. OVERALL SIGNIFICANCE AND FUTURE DIRECTIONS

Reduction in renal mass and function afflicts millions of people worldwide as a consequence of
several renal and non-renal diseases, infections, aging and surgery due to nephrectomy.
Uninephrectomy, or surgical removal of one kidney, is performed for treatment in critical cases
of renal diseases, injuries and for the purpose of kidney transplantation. Due to increasing
incidence of reductions in kidney mass, high medical expenditures represent a significant
challenge to public health care in the U.S. Although the remaining functional renal mass
compensates for the loss of renal function, reduced kidney mass due to nephrectomy is a
pathophysiologic process that is associated with alterations in renal hemodynamics, physiology
and biochemistry.

Numerous human clinical and experimental animal studies have provided evidence that
reduction in renal mass leads to proteinuria, hypertension, hyperfiltration, glomerulosclerosis and
toxicological implications such as increased nephrotoxicity from many drugs. In this study using
a uninephrectomized rat model, we showed that compensatory renal hypertrophy due to
reduction in renal mass is associated with modest renal dysfunction, alterations in renal
mitochondrial glutathione and energetics status and mitochondrial oxidative stress. Furthermore,
we also expanded our previous studies of modulating renal mitochondrial redox status and
showed that an increase in renal mitochondrial GSH status reduces the risk of susceptibility to
cytotoxic chemicals. Thus, we have taken several comprehensive and diversified approaches to
study the role of mitochondrial energetics and redox status in the compensatory renal
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hypertrophy response including in vivo, ex vivo (isolated renal mitochondria), and in vitro (in
primary cultures of PT cells).

Our particular focus on mitochondrial status is significant because alterations in mitochondrial
function have been associated with numerous diverse pathologies. Changes in mitochondrial
redox status likely underlie the regulation of mitochondrial and cellular energetics and cellular
responses to many chemical exposures and pathological disease states. Mitochondrial GSH status
is a critical determinant of cellular energetics and function and plays a critical role in
determining susceptibility of cells to various toxicants. The ability to manipulate mitochondrial
GSH status can provide a tool with which to probe mitochondrial function and modulate cellular
injury upon exposure to various forms of mitochondrial toxicants. In this study, we used such an
approach to alter one of the major GSH compartmentalization mechanisms in renal proximal
tubules of the uninephrectomized rat model to produce protection from nephrotoxicants. Hence,
further understanding of the regulation of mitochondrial GSH status and modulation of GSH
levels in renal mitochondria hold promise for the development of new therapeutic approaches for
many kidney diseases and chemically induced toxicities.

The manipulation of mitochondrial GSH can also be used as a therapeutic target, not only for
compensatory renal hypertrophy or in renal donors, but also for a number of diseases and
pathological states that are associated with the depletion or oxidation of the mitochondrial GSH
pool. For example, chronic ethanol ingestion and alcoholic liver disease are associated with
decreased liver mitochondrial GSH content (Garcia-Ruiz et al., 1994, 1995; Fernandez-Checa et
al., 1987, 1991, 1993, 2002), which also leads to an increase in susceptibility to toxicants (Zhao
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and Slattery 2002; Zhao et al., 2002). Furthermore, cirrhosis and other forms of biliary
obstruction have been associated with mitochondrial dysfunction caused by depletion of the
matrix GSH pool (Krahenbuhl et al., 1992, 1995) and Type 2 diabetes has also been linked with
depletion and oxidation of mitochondrial GSH in rat brain, heart and kidney (Santos et al., 2003;
Mastrocola et al., 2005; Rosca et al., 2005), suggesting the importance of regulation of
mitochondrial GSH. Clearly, it becomes apparent that it is important to design
pharmacologically-based strategies aimed at specific targets in transport and catabolism of GSH
as a potential therapeutic treatment against human kidney diseases, chemically induced toxicities
and health complications in renal donors. Thus, reducing complications after nephrectomy will
also directly increase the quality of life for a renal donor.

Overall, the observations in this study enabled us to more completely define the phenotype for
compensatory renal hypertrophy both in vivo and in an ex vivo model using primary culture of
PT cells. This in turn also helped us to understand the biochemistry and toxicology of
compensatory renal hypertrophy and provided a basis to reduce the risk of mitochondrial
dysfunction and susceptibility to toxicants due to reduction in functional renal mass. With the
basic knowledge acquired in this study, further studies of the protective effects of enhancing
mitochondrial redox status and reversing deleterious properties of hypertrophied PT cells might
provide a basis for novel therapeutic approaches to counteract the increased potential for renal
insufficiency due to reduced functional renal mass.

Future studies need to further explore the effect of overexpression of mitochondrial GSH
transporters on oxidative stress, proliferation and cellular GSH status. Furthermore, it would be
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interesting to examine a more comprehensive range of transporter expression and activity by also
decreasing the expression and activity of the two mitochondrial GSH transporters, the DIC and
OGC.
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A reduction in functional renal mass occurs in humans during aging and severe kidney
damage from diseases, injuries, infections and congenital conditions and after nephrectomy.
Nephrectomy, or surgical removal of a kidney or a section of a kidney, is performed for
treatment of unilateral secondary renal cancer, infections and for kidney transplantation. As a
result, the remaining renal tissue undergoes compensatory growth due primarily to hypertrophy,
in which both the size and functional capacity of the remaining kidney are increased. Renal
compensatory hypertrophy is associated with a series of physiological, morphological and
biochemical changes that also have toxicological implications.
Previous studies have shown that compensatory renal cellular hypertrophy after
uninephrectomy resulted in a hypermetabolic state, increased glutathione (GSH) content, but
higher renal oxidative stress. These changes are also associated with increased susceptibility of
renal proximal tubule cells to several drugs and environmental chemicals. Furthermore, our lab
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also showed that overexpression of mitochondrial GSH transporters, the dicarboxylate (DIC,
Slc25a10) and 2-oxoglutarate (OGC, Slc25a11) carriers, in NRK-52E cells, which are derived
from normal rat kidney proximal tubules, exhibited increased mitochondrial GSH uptake,
contents of GSH and protection from chemically induced apoptosis from exposure to
nephrotoxicants.
Based on these previous observations, we hypothesized that compensatory renal
hypertrophy after uninephrectomy alters renal function in vivo and mitochondrial status and
modulation of mitochondrial redox status alters susceptibility to nephrotoxicants in the remnant
kidney. In this study, we used a uninephrectomized (NPX) rat model to induce compensatory
renal growth. Our results show alterations in renal physiological parameters consistent with
modest renal injury, altered renal cellular energetics, upregulation of certain renal plasma
membrane transporters, including some that have been observed to transport GSH, and evidence
of increased oxidative stress in mitochondria from the remnant kidney of NPX rats. Our present
results provide further evidence that compensatory renal hypertrophy is associated with
mitochondrial hypertrophy and hyperpolarization and manipulation of mitochondrial GSH
transporters in PT cells of hypertrophied kidney alters susceptibility to chemically induced
injury. These studies provide additional insight into the molecular changes that occur in
compensatory renal hypertrophy and should help in the development of novel therapeutic
approaches for patients with reduced renal mass.
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